1 |
(+)-(s)-2-(6-methoxynaphthalen-2-yl) propanoic acid |
Propanoic acid |
[1] D02310 D02310 💬 |
- |
- |
271 [1] 271 💬 |
2 |
(2r)-2-propyloctanoic acid |
- |
- |
- |
- |
002 [1] 2 💬 |
3 |
(2s)-2-[(4r)-2-oxo-4-propylpyrrolidin-1-y1] butanamide |
- |
- |
- |
- |
309 [1] 309 💬 |
4 |
(2s)-2-[(4r)-2-oxo-4-propylpyrrolidin-1-yl] butanamide |
- |
- |
- |
- |
309 [1] 309 💬 |
5 |
(6r)-4, 5, 6, 7 - tetrahydro-n6-propyl-2,6-benzothiazolidiamine dihydrochloride monohydrate |
- |
- |
- |
- |
002 [1] 2 💬 |
6 |
(6s)-6-{propyl-[2-[2-thienyl]ethyl]amino}-5,6,7,8-tetrahydro-1-naphtalenol |
- |
- |
- |
- |
006 [1] 6 💬 |
7 |
(r)-(-)-2-propyloctaroic acid |
- |
- |
- |
- |
002 [1] 2 💬 |
8 |
(r)-3-(1-oxo-propoxy)-4-(n,n,n-trimethyl amonium chloride)-butanoic acid |
Butyric Acid |
[1] D05866 D05866 💬 |
- |
- |
097 [1] 97 💬 |
9 |
(s)- 2- amino- 4,5,6,7- tetrahydro- 6- (propylamino)benzothiazol |
- |
- |
- |
- |
006 [1] 6 💬 |
10 |
(s)-3-((3-(1-((6-(3,4-dimethoxyphenyl)pryazin-2-yl)amino)ethyl)phenyl)carbamoyl)-5-methylpridin-1-ium |
- |
- |
- |
- |
086 [1] 86 💬 |
11 |
**comment**- imp inhalation solution identical to ventavis inhalation solution, but imp is in a different volume presentation. please see covering letter. |
- |
- |
- |
- |
086 [1] 86 💬 |
12 |
0 mg prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
044 [1] 44 💬 |
13 |
0,5 mg prevenar i.m. |
- |
- |
- |
- |
051 [1] 51 💬 |
14 |
10% nifedipine cream |
Nifedipine |
[1] D00437 D00437 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
050 [1] 50 💬 |
15 |
10% nitroglycerine in propylene glycol, usp |
Nitroglycerin |
[2] D00078 D00078, D00515 D00515 💬 |
- |
- |
051 [1] 51 💬 |
16 |
17beta-hydroxy-11beta-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one |
- |
- |
- |
- |
075 [1] 75 💬 |
17 |
17ß-hydroxy-11ß-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one |
- |
- |
- |
- |
075 [1] 75 💬 |
18 |
1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- |
- |
- |
- |
- |
006 [1] 6 💬 |
19 |
1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea |
- |
- |
- |
- |
006 [1] 6 💬 |
20 |
1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- |
- |
- |
- |
- |
006 [1] 6 💬 |
21 |
1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea |
- |
- |
- |
- |
006 [1] 6 💬 |
22 |
2'-o-(2-methoxyethyl)-d-ribose antisense oligonucleotide targeting glial fibrillary acidic protein messenger ribonucleic acid |
Ribose |
- |
- |
- |
131 [1] 131 💬 |
23 |
2-(2-(2-amino-9h-purin-9-yl)ethyl)-1,3-propanediol diacetate ester |
- |
- |
- |
- |
013 [1] 13 💬 |
24 |
3-(3-(3,5-dimethyl-1h-pyrazol-4-yl)propoxy)-4-fluorobenzoic acid |
Pyrazole |
- |
- |
- |
028 [1] 28 💬 |
25 |
5 mg prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
044 [1] 44 💬 |
26 |
5% lidocaine/5 mg/ml 0.02% estradiol compound cream |
Estradiol |
[11] D00105 D00105, D00358 D00358, D01413 D01413, D01617 D01617, D01953 D01953, D02086 D02086, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065, D08127 D08127 💬 |
ESR1 [7] ESR1, ESR2, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [12] Adrenergic signaling in cardiomyocytes, Breast cancer, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway |
226 [1] 226 💬 |
27 |
5-aminosalicylic acid(5-asa) and/or prednisone |
Aminosalicylic acid |
[3] D00162 D00162, D00377 D00377, D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
28 |
5-probe cocktail |
- |
- |
- |
- |
254 [1] 254 💬 |
29 |
68ga-bnota-prgd2 |
- |
- |
- |
- |
046 [1] 46 💬 |
30 |
90 mg hydrocortisone acetate suppository with sephure suppository applicator |
Acetate |
[2] D00088 D00088, D00165 D00165 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
31 |
[rvt-1601 (in precedenza pa101b)] |
- |
- |
- |
- |
085 [1] 85 💬 |
32 |
A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (cbus) |
- |
- |
- |
- |
060 [1] 60 💬 |
33 |
A multistrain probiotic product (dsf) |
- |
- |
- |
- |
097 [1] 97 💬 |
34 |
Abatacept prefilled syringe |
Abatacept |
[1] D03203 D03203 💬 |
CD80 [2] CD80, CD86 💬 |
Allograft rejection [12] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
046 [1] 46 💬 |
35 |
Abp 959 - proposed biosimilar to eculizumab |
Eculizumab |
[1] D03940 D03940 💬 |
C5 [1] C5 💬 |
Complement and coagulation cascades [9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 [1] 62 💬 |
36 |
Access program - sildenafil citrate, viagra, revatio |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
37 |
Act-385781a (actelion epoprostenol) |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
38 |
Acthar injectable product |
- |
- |
- |
- |
046 [1] 46 💬 |
39 |
Adalimumab prn |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
40 |
Adalimumab, plus prednisone |
Adalimumab |
[2] D00473 D00473, D02597 D02597 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
41 |
Adalimumab, solution for injection 40 mg/ (0.8 ml) pre-filled syringe |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
42 |
Adeno-associated viral (aav) serotype 8 (aav2/8) vector with liver-specific thyroxine-binding globulin (tbg) promoter, driving the expression of the human arsb gene |
Levothyroxine |
[2] D01010 D01010, D08125 D08125 💬 |
THRA [2] THRA, THRB 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
019 [1] 19 💬 |
43 |
Advagraf prolonged-release hard capsules |
- |
- |
- |
- |
299 [1] 299 💬 |
44 |
Agua para preparaciones inyectables |
- |
- |
- |
- |
078 [1] 78 💬 |
45 |
Aldesleukin |
Aldesleukin |
[1] D00748 D00748 💬 |
IL2RA [3] IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction [14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
049 [4] 49, 65, 96, 97 💬 |
46 |
Alirocumab |
Alirocumab |
[1] D10335 D10335 💬 |
PCSK9 [1] PCSK9 💬 |
Cholesterol metabolism [1] Cholesterol metabolism |
079 [1] 79 💬 |
47 |
Alirocumab sar236553 (regn727) |
Alirocumab |
[1] D10335 D10335 💬 |
PCSK9 [1] PCSK9 💬 |
Cholesterol metabolism [1] Cholesterol metabolism |
079 [1] 79 💬 |
48 |
Alkalinized lidocaine-heparin |
Heparin |
[4] D00358 D00358, D02086 D02086, D07510 D07510, D08127 D08127 💬 |
SCN1A [6] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 |
Adrenergic signaling in cardiomyocytes [4] Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction |
226 [1] 226 💬 |
49 |
Allogeneic mesenchymal precursor cells |
- |
- |
- |
- |
046 [1] 46 💬 |
50 |
Allogeneic neural retina-derived human neural retinal progenitor cells ex vivo expanded |
- |
- |
- |
- |
090 [1] 90 💬 |
51 |
Alpha 1-proteinase inhibitor |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 [1] 231 💬 |
52 |
Alpha 1-proteinase inhibitor (human) |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 [1] 231 💬 |
53 |
Alpha-1 proteinase inhibitor (human) |
- |
- |
- |
- |
231 [1] 231 💬 |
54 |
Alpha1-proteinase inhibitor |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 [2] 231, 299 💬 |
55 |
Alpha1-proteinase inhibitor (human) |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 [2] 231, 299 💬 |
56 |
Alprostadil |
Alprostadil |
[2] D00180 D00180, D02705 D02705 💬 |
PTGER1 [1] PTGER1 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer |
051 [2] 51, 70 💬 |
57 |
Ambrisentan 5mg film-coated tablets [marketed product] |
Ambrisentan |
[1] D07077 D07077 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
58 |
Amitriptyline, fluoxetine and tramadol alone (control group) |
Amitriptyline |
[6] D00326 D00326, D00809 D00809, D00823 D00823, D01355 D01355, D07448 D07448, D08623 D08623 💬 |
OPRM1 [3] OPRM1, SLC6A2, SLC6A4 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
078 [1] 78 💬 |
59 |
Amorphous calcium carbonate |
Calcium |
[2] D00932 D00932, D10802 D10802 💬 |
- |
- |
235 [1] 235 💬 |
60 |
Androgel 10 grams of gel containing 100 mg of testosterone |
Testosterone |
[6] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
013 [1] 13 💬 |
61 |
Antioxidant plus pregabalin |
Pregabalin |
[1] D02716 D02716 💬 |
CACNA2D1 [4] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 |
Adrenergic signaling in cardiomyocytes [7] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
298 [1] 298 💬 |
62 |
Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
63 |
Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
64 |
Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
65 |
Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
66 |
Atenolol or propranolol |
Atenolol |
[3] D00235 D00235, D00483 D00483, D08443 D08443 💬 |
ADRB1 [3] ADRB1, ADRB2, ADRB3 💬 |
Adrenergic signaling in cardiomyocytes [11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway |
167 [1] 167 💬 |
67 |
Autologous ex vivo gene therapy products based on the efs lv encoding for the human adenosine deaminase (ada) gene (efs-ada lv) |
Adenosine |
[1] D00045 D00045 💬 |
ADORA1 [4] ADORA1, ADORA2A, ADORA2B, ADORA3 💬 |
Alcoholism [12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
065 [1] 65 💬 |
68 |
Autologous mesenchymal cell product |
- |
- |
- |
- |
013 [1] 13 💬 |
69 |
Avatrombopag (proposed) |
Avatrombopag |
[1] D10306 D10306 💬 |
- |
- |
063 [1] 63 💬 |
70 |
Avxs-101 (previously known as scaav9.cb.smn) |
- |
- |
- |
- |
003 [1] 3 💬 |
71 |
Azathioprine/prednisone |
Azathioprine |
[3] D00238 D00238, D00473 D00473, D03033 D03033 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
085 [1] 85 💬 |
72 |
Azd4017 and prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
075 [1] 75 💬 |
73 |
Bacteriophage preparation |
- |
- |
- |
- |
096 [1] 96 💬 |
74 |
Bascial prescription plus or minus herbs depend on symptoms |
- |
- |
- |
- |
097 [1] 97 💬 |
75 |
Befizal l.p. 400 mg, comprimé enrobé à libération prolongée |
- |
- |
- |
- |
094 [1] 94 💬 |
76 |
Behavioral: 6 months weight resistance and balance program |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
77 |
Behavioral: administration of probiotic (l. rhamnosus and l. acidophilus) |
Lactobacillus acidophilus |
[1] D04349 D04349 💬 |
- |
- |
097 [1] 97 💬 |
78 |
Behavioral: co-op treatment protocol |
- |
- |
- |
- |
006 [1] 6 💬 |
79 |
Behavioral: gait and balance training program |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
80 |
Behavioral: heart health educational program |
- |
- |
- |
- |
049 [1] 49 💬 |
81 |
Behavioral: protein and calorie controlled diet |
- |
- |
- |
- |
251 [1] 251 💬 |
82 |
Betamethasone |
Betamethasone |
[7] D00244 D00244, D00972 D00972, D01357 D01357, D01402 D01402, D01637 D01637, D02032 D02032, D02286 D02286 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [6] 2 , 28, 46, 90, 96, 235 💬 |
83 |
Betamethasone acibutate |
Betamethasone |
[7] D00244 D00244, D00972 D00972, D01357 D01357, D01402 D01402, D01637 D01637, D02032 D02032, D02286 D02286 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
84 |
Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days |
Acetate |
[7] D00244 D00244, D00972 D00972, D01357 D01357, D01402 D01402, D01637 D01637, D02032 D02032, D02286 D02286 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [1] 2 💬 |
85 |
Bi 695501 prefilled syringe |
- |
- |
- |
- |
046 [1] 46 💬 |
86 |
Biib019 (daclizumab high yield process) |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
87 |
Biib041 (pr fampridine) |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
88 |
Bio-25 probiotic |
- |
- |
- |
- |
299 [1] 299 💬 |
89 |
Biosimilar product to adalimumab |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
90 |
Bladder instillation with heparin/ lidocaine |
Heparin |
[4] D00358 D00358, D02086 D02086, D07510 D07510, D08127 D08127 💬 |
SCN1A [6] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 |
Adrenergic signaling in cardiomyocytes [4] Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction |
226 [1] 226 💬 |
91 |
Bladder instillation with triamcinolone acetonide |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
226 [1] 226 💬 |
92 |
Bladder instillation without triamcinolone acetonide |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
226 [1] 226 💬 |
93 |
Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) |
Digoxin |
[13] D00298 D00298, D00330 D00330, D00455 D00455, D00529 D00529, D00550 D00550, D00696 D00696, D01207 D01207, D01475 D01475, D02290 D02290, D05028 D05028, D05259 D05259, D05261 D05261, D08229 D08229 💬 |
ATP1A1 [25] ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP4A, ATP4B, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, PTGS1, PTGS2 💬 |
Adrenergic signaling in cardiomyocytes [49] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis, Collecting duct acid secretion, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
94 |
Bortezomib/dexamethasone |
Bortezomib |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150 💬 |
NR3C1 [2] NR3C1, PSMB5 💬 |
Alzheimer disease [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
283 [1] 283 💬 |
95 |
Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone |
Bortezomib |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150 💬 |
NR3C1 [2] NR3C1, PSMB5 💬 |
Alzheimer disease [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
028 [1] 28 💬 |
96 |
Botox 100 unites allergan (pr1) |
- |
- |
- |
- |
002 [1] 2 💬 |
97 |
Btt1023 iv infusion 20 mg/ml, 5 ml drug product |
- |
- |
- |
- |
094 [1] 94 💬 |
98 |
Budesonide 6 mg capsules, hard (bux-pvii prototype) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
99 |
Budesonide 6 mg prolonged-release capsule, hard (bux-pvii prototype) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
100 |
Budesonide 6 mg prolonged-release capsules, hard (bux-pvii prototype) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
101 |
Budesonide 9 mg capsules, hard (bux-pvii prototype) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
102 |
Budesonide 9 mg prolonged-release capsule, hard (bux-pvii prototype) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
103 |
Budesonide 9 mg prolonged-release capsules, hard (bux-pvii prototype) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
104 |
Budesonide plus prevacid |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
105 |
Bupivacaine/epinephrine/dexamethasone |
Bupivacaine |
[14] D00095 D00095, D00292 D00292, D00975 D00975, D00996 D00996, D01450 D01450, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02149 D02149, D02174 D02174, D02591 D02591, D02592 D02592, D07552 D07552 💬 |
ADRA1A [15] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [15] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [1] 96 💬 |
106 |
Buprenorphine |
Buprenorphine |
[2] D00836 D00836, D07132 D07132 💬 |
OPRK1 [2] OPRK1, OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 [2] 46, 70 💬 |
107 |
Buprenorphine transdermal patch |
Buprenorphine |
[2] D00836 D00836, D07132 D07132 💬 |
OPRK1 [2] OPRK1, OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
108 |
Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf |
Busulfan |
[8] D00107 D00107, D00142 D00142, D00248 D00248, D01907 D01907, D02115 D02115, D03235 D03235, D07966 D07966, D08556 D08556 💬 |
CSF3R [9] CSF3R, DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, RRM1 💬 |
Alzheimer disease [46] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Drug metabolism - other enzymes, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 [1] 60 💬 |
109 |
Bydureon 2 mg powder and solvent for prolonged-release suspension |
- |
- |
- |
- |
006 [1] 6 💬 |
110 |
C326, il-6 inhibitory avimer protein |
- |
- |
- |
- |
096 [1] 96 💬 |
111 |
Calcium carbonate |
Calcium |
[2] D00932 D00932, D10802 D10802 💬 |
- |
- |
013 [8] 13, 19, 46, 53, 75, 96, 235, 299 💬 |
112 |
Calcium carbonate and alphacalcidol |
Calcium |
[2] D00932 D00932, D10802 D10802 💬 |
- |
- |
235 [1] 235 💬 |
113 |
Calcium carbonate d |
Calcium |
[2] D00932 D00932, D10802 D10802 💬 |
- |
- |
053 [1] 53 💬 |
114 |
Calcium lactate |
Calcium |
[2] D00936 D00936, D02254 D02254 💬 |
- |
- |
235 [1] 235 💬 |
115 |
Canakinumab (proposed) |
Canakinumab |
[1] D09315 D09315 💬 |
IL1B [1] IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications [42] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
046 [1] 46 💬 |
116 |
Cardiovascular profile |
- |
- |
- |
- |
113 [1] 113 💬 |
117 |
Caveolin-1-scaffolding-protein-derived peptide (lti-03) |
- |
- |
- |
- |
085 [1] 85 💬 |
118 |
Cd34+ enriched, t cell depleted donor stem cell product |
- |
- |
- |
- |
326 [1] 326 💬 |
119 |
Certolizumab pegol (cdp870, tradename cimzia)(prefilled syringes at the dose of 200mg) |
Certolizumab pegol |
[1] D03441 D03441 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
120 |
Cgmp protein |
- |
- |
- |
- |
097 [1] 97 💬 |
121 |
Chinese herb prescription granule plus prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
122 |
Cipro (ciprofloxacin, bayq3939) |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
123 |
Ciprofloxacin |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
002 [5] 2 , 60, 96, 97, 299 💬 |
124 |
Ciprofloxacin (bayq3939) dry powder for inhalation |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
125 |
Ciprofloxacin (cipro inhale, bayq3939) |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
126 |
Ciprofloxacin (cipro, bayq3939) |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
127 |
Ciprofloxacin (ciproxin) |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
128 |
Ciprofloxacin dispersion for inhalation |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
129 |
Ciprofloxacin dpi |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
130 |
Ciprofloxacin dpi (bayq3939) |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
131 |
Ciprofloxacin for inhalation |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
132 |
Ciprofloxacin hydrochloride |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
096 [2] 96, 299 💬 |
133 |
Ciprofloxacin hydrochloride monohydrate |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
134 |
Ciprofloxacin inhale |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
135 |
Circadin 2 mg comprimidos de liberación prolongada |
- |
- |
- |
- |
090 [1] 90 💬 |
136 |
Cis-4-hydroxy-l-proline |
Proline |
[1] D00035 D00035 💬 |
- |
- |
094 [1] 94 💬 |
137 |
Cisapride |
Cisapride |
[2] D00274 D00274, D02092 D02092 💬 |
HTR2A [3] HTR2A, HTR3A, HTR4 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
138 |
Clartihromycin, amoxicillin, and omeprazole |
Amoxicillin |
[7] D00229 D00229, D00455 D00455, D01207 D01207, D02925 D02925, D05259 D05259, D05261 D05261, D07452 D07452 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 [1] 6 💬 |
139 |
Clobetasol propionate |
Clobetasol |
[2] D01272 D01272, D07715 D07715 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [2] 46, 162 💬 |
140 |
Clobetasol propionate + methotrexate |
Clobetasol |
[4] D00142 D00142, D01272 D01272, D02115 D02115, D07715 D07715 💬 |
DHFR [3] DHFR, DHFR2, NR3C1 💬 |
Antifolate resistance [6] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate |
162 [1] 162 💬 |
141 |
Clobetasol propionate alone |
Clobetasol |
[2] D01272 D01272, D07715 D07715 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
162 [1] 162 💬 |
142 |
Clobetasol propionate cream treatment |
Clobetasol |
[2] D01272 D01272, D07715 D07715 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
162 [1] 162 💬 |
143 |
Coenzyme q10 and lisinopril |
Lisinopril |
[3] D00362 D00362, D01065 D01065, D08131 D08131 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
113 [1] 113 💬 |
144 |
Colal pred |
- |
- |
- |
- |
097 [1] 97 💬 |
145 |
Colal-pred |
- |
- |
- |
- |
097 [1] 97 💬 |
146 |
Colal-pred® |
- |
- |
- |
- |
097 [1] 97 💬 |
147 |
Colistimethate sodium (promixin) |
Colistimethate |
[1] D02049 D02049 💬 |
- |
- |
299 [1] 299 💬 |
148 |
Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine |
Azathioprine |
[12] D00238 D00238, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D02994 D02994, D03033 D03033 💬 |
MS4A1 [2] MS4A1, NR3C1 💬 |
Hematopoietic cell lineage [2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction |
035 [1] 35 💬 |
149 |
Combination oral budesonide and rectal hydrocortisone |
Budesonide |
[2] D00088 D00088, D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
150 |
Combination product (natpara) and drug or supplements [disease and drug registry] |
- |
- |
- |
- |
235 [1] 235 💬 |
151 |
Combination product: device: axially oscillating sphere dry powder inhaler (aos dpi) |
- |
- |
- |
- |
086 [1] 86 💬 |
152 |
Combination product: active treatment with dual therapy |
- |
- |
- |
- |
002 [1] 2 💬 |
153 |
Combination product: beclomethasone dipropionate in addition to mc-evoo |
Beclomethasone dipropionate |
[2] D00689 D00689, D07495 D07495 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
154 |
Combination product: beclomethasone dipropionate in addition to refined oil |
Beclomethasone dipropionate |
[2] D00689 D00689, D07495 D07495 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
155 |
Combination product: belimumab |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
156 |
Combination product: goldic serum |
- |
- |
- |
- |
070 [1] 70 💬 |
157 |
Combination product: hyperbaric oxygen therapy- |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
226 [1] 226 💬 |
158 |
Combination product: implantable system for remodulin (treprostinil) |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
159 |
Combination product: l-dopa 140 mg |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
160 |
Combination product: l-dopa 35 mg |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
161 |
Combination product: l-dopa 70mg |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
162 |
Combination product: l-dopa 70mg/carbidopa 7mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
163 |
Combination product: mavrilimumab |
Mavrilimumab |
[1] D09930 D09930 💬 |
CSF2RA [1] CSF2RA 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
041 [1] 41 💬 |
164 |
Combination product: methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
165 |
Combination product: nd0612 solution for sc infusion |
- |
- |
- |
- |
006 [1] 6 💬 |
166 |
Combination product: ofatumumab with ai |
Ofatumumab |
[1] D09314 D09314 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
167 |
Combination product: ofatumumab with prf |
Ofatumumab |
[1] D09314 D09314 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
168 |
Combination product: prp combined magnovision |
- |
- |
- |
- |
090 [1] 90 💬 |
169 |
Combination product: transcon pth |
- |
- |
- |
- |
235 [1] 235 💬 |
170 |
Combination product: treprostinil via implanted pump |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
171 |
Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator |
Acetate |
[2] D00088 D00088, D00165 D00165 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
172 |
Combination therapy with vigabatrin and prednisolone |
Prednisolone |
[9] D00472 D00472, D00535 D00535, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
ABAT [2] ABAT, NR3C1 💬 |
Alanine, aspartate and glutamate metabolism [8] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
145 [1] 145 💬 |
173 |
Continuation of current haart (boosted protease inhibitor [pi] combination + 2 nrtis) |
- |
- |
- |
- |
265 [1] 265 💬 |
174 |
Control intervention (no dexamethasone) |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
175 |
Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) |
Acetate |
[21] D00088 D00088, D00292 D00292, D00472 D00472, D00473 D00473, D00973 D00973, D00975 D00975, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D01998 D01998, D02156 D02156, D02174 D02174, D02591 D02591, D02592 D02592, D03301 D03301, D07749 D07749 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
176 |
Copaxone - 20 mg/ml soluzione iniettabile in siringhe preriempite 30 siringhe |
- |
- |
- |
- |
013 [1] 13 💬 |
177 |
Copaxone - 40 mg/ml soluzione iniettabile in siringa preriempita 12 siringhe preriempite da 1 ml con ago |
- |
- |
- |
- |
013 [1] 13 💬 |
178 |
Copaxone 20 mg/ml solución inyectable en jeringa precargada |
- |
- |
- |
- |
013 [1] 13 💬 |
179 |
Copaxone 20 mg/ml solución para inyección en jeringa precargada |
- |
- |
- |
- |
013 [1] 13 💬 |
180 |
Copaxone 20 mg/ml solution for injection, pre-filled syringe |
- |
- |
- |
- |
013 [1] 13 💬 |
181 |
Copaxone 20 mg/ml, solution for injection, pre-filled syringes |
- |
- |
- |
- |
013 [1] 13 💬 |
182 |
Copaxone 20mg/ml solution for injection, pre-filled syringe |
- |
- |
- |
- |
013 [1] 13 💬 |
183 |
Copaxone 40 mg/ml solution for injection, pre-filled syringe |
- |
- |
- |
- |
013 [1] 13 💬 |
184 |
Cortef (hydrocortisone) |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
083 [1] 83 💬 |
185 |
Corticosteroid (prednisolone) |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
085 [1] 85 💬 |
186 |
Corticosteroid treatment (methylprednisolone or prednisolone) |
Methylprednisolone |
[14] D00407 D00407, D00472 D00472, D00751 D00751, D00979 D00979, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
064 [1] 64 💬 |
187 |
Corticosteroids (prednisone or prednisolone) |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [1] 49 💬 |
188 |
Current marketed flolan (epoprostenol sodium) |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
189 |
Cyclo[l-alanyl-l-seryl-l-isoleucyl-l-prolyl-l-prolyl-l-glutaminyl-l-lysyl-l-tyrosyl-d-prolyl-l-prolyl-(2s)-2-aminodecanoyl-l-alpha-glutamyl-l-threonyl] |
- |
- |
- |
- |
299 [1] 299 💬 |
190 |
Cyclophosphamide + pred |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
283 [1] 283 💬 |
191 |
Cyclophosphamide, azathioprine,prednisone,methylprednisolone |
Azathioprine |
[11] D00238 D00238, D00287 D00287, D00407 D00407, D00473 D00473, D00751 D00751, D00979 D00979, D03033 D03033, D05000 D05000, D05001 D05001, D05002 D05002, D07760 D07760 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
042 [3] 42, 43, 45 💬 |
192 |
Cyclophosphamide, bortezomib, and dexamethasone (cybord) |
Bortezomib |
[12] D00287 D00287, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150, D07760 D07760 💬 |
NR3C1 [2] NR3C1, PSMB5 💬 |
Alzheimer disease [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
028 [1] 28 💬 |
193 |
Cyclophosphamide, bortezomib, dexamethasone |
Bortezomib |
[12] D00287 D00287, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150, D07760 D07760 💬 |
NR3C1 [2] NR3C1, PSMB5 💬 |
Alzheimer disease [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
028 [1] 28 💬 |
194 |
Cyclophosphamide, bortezomib, dexamethasone plus daratumumab |
Bortezomib |
[13] D00287 D00287, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150, D07760 D07760, D10777 D10777 💬 |
CD38 [3] CD38, NR3C1, PSMB5 💬 |
Alzheimer disease [16] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia |
028 [1] 28 💬 |
195 |
Cyclophosphamide-prednisone-azathioprine |
Azathioprine |
[5] D00238 D00238, D00287 D00287, D00473 D00473, D03033 D03033, D07760 D07760 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [1] 49 💬 |
196 |
Cyclosporin, methotrexate (gvhd prophylaxis) |
Cyclosporine |
[3] D00142 D00142, D00184 D00184, D02115 D02115 💬 |
DHFR [7] DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [37] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
326 [1] 326 💬 |
197 |
Cyclosporine oral product |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 [1] 60 💬 |
198 |
D-proline |
D-Proline |
[1] D00035 D00035 💬 |
- |
- |
097 [1] 97 💬 |
199 |
D.3.2 product code where applicable13: |
- |
- |
- |
- |
193 [1] 193 💬 |
200 |
Dabigatran etexilate |
Dabigatran |
[2] D07144 D07144, D09707 D09707 💬 |
F2 [1] F2 💬 |
Complement and coagulation cascades [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton |
051 [1] 51 💬 |
201 |
Daclizumab high yield process |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
202 |
Decortin (prednisona) 5 mg comprimidos |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
203 |
Denosumab |
Denosumab |
[1] D03684 D03684 💬 |
TNFSF11 [1] TNFSF11 💬 |
Breast cancer [7] Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis |
046 [7] 46, 50, 93, 95, 96, 274, 299 💬 |
204 |
Denosumab - - immunoglobulin g2 human monoclonal antibody to rank ligand |
Denosumab |
[1] D03684 D03684 💬 |
TNFSF11 [1] TNFSF11 💬 |
Breast cancer [7] Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis |
274 [1] 274 💬 |
205 |
Denosumab - immunoglobulin g2 human monoclonal antibody to rank ligand |
Denosumab |
[1] D03684 D03684 💬 |
TNFSF11 [1] TNFSF11 💬 |
Breast cancer [7] Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis |
274 [1] 274 💬 |
206 |
Device: abatacept combination product (acp) |
Abatacept |
[1] D03203 D03203 💬 |
CD80 [2] CD80, CD86 💬 |
Allograft rejection [12] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
046 [1] 46 💬 |
207 |
Device: avonex prefilled syringe via manual im injection |
- |
- |
- |
- |
013 [1] 13 💬 |
208 |
Device: biib017 (peginterferon beta-1a) pre-filled syringe (pfs) |
Peginterferon beta-1a |
[1] D10483 D10483 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
209 |
Device: blood pressure |
- |
- |
- |
- |
084 [1] 84 💬 |
210 |
Device: cell processing for tcrabeta+/cd19+ depletion |
- |
- |
- |
- |
065 [1] 65 💬 |
211 |
Device: cell processing for tcraß+/cd19+ depletion |
- |
- |
- |
- |
065 [1] 65 💬 |
212 |
Device: cic using lofric primo |
- |
- |
- |
- |
013 [1] 13 💬 |
213 |
Device: dexamethasone injection |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
090 [1] 90 💬 |
214 |
Device: heparin-induced extracorporeal ldl precipitation |
Heparin |
[1] D07510 D07510 💬 |
SERPINC1 [1] SERPINC1 💬 |
Complement and coagulation cascades [1] Complement and coagulation cascades |
079 [1] 79 💬 |
215 |
Device: iowa oral pressure instrument |
- |
- |
- |
- |
002 [1] 2 💬 |
216 |
Device: micro mouth pressure meter |
- |
- |
- |
- |
002 [1] 2 💬 |
217 |
Device: nocturnal oxygen , nocturnal bi-level positive pressure ventilation |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
299 [1] 299 💬 |
218 |
Device: positive expiratory pressure |
- |
- |
- |
- |
299 [1] 299 💬 |
219 |
Device: pre-filled syringe (pfs) |
- |
- |
- |
- |
046 [1] 46 💬 |
220 |
Device: primus fgti (flexible great toe implant) |
Florasulam |
- |
- |
- |
046 [1] 46 💬 |
221 |
Device: propofol dosage |
Propofol |
[1] D00549 D00549 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
084 [1] 84 💬 |
222 |
Device: reciprocating procedure device (rpd) - avanca re no. 1091001 |
- |
- |
- |
- |
046 [1] 46 💬 |
223 |
Device: single-use autoinjector with a prefilled liquid avonex syringe |
- |
- |
- |
- |
013 [1] 13 💬 |
224 |
Device: the ozone generator device (human pro medic, german) |
Ozone |
- |
- |
- |
051 [1] 51 💬 |
225 |
Dexamethasone |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [25] 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
226 |
Dexamethasone (1 cycle) |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
063 [1] 63 💬 |
227 |
Dexamethasone (4 cycles) |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
063 [1] 63 💬 |
228 |
Dexamethasone (50mg 1dd6, 3 consecutive days/month) |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [1] 35 💬 |
229 |
Dexamethasone 0,1 mg tablets |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
230 |
Dexamethasone 0,5mg |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
084 [1] 84 💬 |
231 |
Dexamethasone 0.5mg tablet |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
232 |
Dexamethasone 0.5mg/5ml solution |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [2] 35, 162 💬 |
233 |
Dexamethasone 0.5mg/5ml solution in mucolox™ |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [2] 35, 162 💬 |
234 |
Dexamethasone 1,5 mg tablets |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
235 |
Dexamethasone 21-dihydrogen phosphate |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
065 [1] 65 💬 |
236 |
Dexamethasone 21-phosphate |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
237 |
Dexamethasone 2mg tablets |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
238 |
Dexamethasone 4 mg jenapharm |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
028 [1] 28 💬 |
239 |
Dexamethasone abcur |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
063 [1] 63 💬 |
240 |
Dexamethasone and rituximab |
Dexamethasone |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D02994 D02994 💬 |
MS4A1 [2] MS4A1, NR3C1 💬 |
Hematopoietic cell lineage [2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction |
063 [1] 63 💬 |
241 |
Dexamethasone oral tablet 8mg (dexamethasone krka tablets(8mg), warsaw, poland). |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
235 [1] 235 💬 |
242 |
Dexamethasone parotid irrigation |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
053 [1] 53 💬 |
243 |
Dexamethasone sodium phosphate |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
065 [3] 65, 70, 96 💬 |
244 |
Dexamethasone sodium phosphate 250 mg/ 10 ml |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
245 |
Dexamethasone sodium phosphate 250 mg/10 ml solution |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
299 [1] 299 💬 |
246 |
Dexamethasone sodium phosphate ph. eur. |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
065 [1] 65 💬 |
247 |
Dexamethasone sodium sulfate |
Dexamethasone |
[11] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01732 D01732, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D05877 D05877 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
028 [1] 28 💬 |
248 |
Dexamethasone soduim phosphate |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
249 |
Dexamethasone, 40 mg |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
028 [1] 28 💬 |
250 |
Dexmedetomidine |
Dexmedetomidine |
[2] D00514 D00514, D01205 D01205 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
002 [12] 2 , 4 , 6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬 |
251 |
Dexmedetomidine 1 |
Dexmedetomidine |
[2] D00514 D00514, D01205 D01205 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
280 [1] 280 💬 |
252 |
Dexmedetomidine 2 |
Dexmedetomidine |
[2] D00514 D00514, D01205 D01205 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
280 [1] 280 💬 |
253 |
Dexmedetomidine 3 |
Dexmedetomidine |
[2] D00514 D00514, D01205 D01205 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
280 [1] 280 💬 |
254 |
Dexmedetomidine group |
Dexmedetomidine |
[2] D00514 D00514, D01205 D01205 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
070 [1] 70 💬 |
255 |
Dexmedetomidine hydrochloride |
Dexmedetomidine |
[2] D00514 D00514, D01205 D01205 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
070 [1] 70 💬 |
256 |
Dexmedetomidine hydrochloride infusion |
Dexmedetomidine |
[2] D00514 D00514, D01205 D01205 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
257 |
Dexmedetomidine with ropivacaine |
Dexmedetomidine |
[4] D00514 D00514, D01205 D01205, D04048 D04048, D08490 D08490 💬 |
ADRA2A [8] ADRA2A, ADRA2B, ADRA2C, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [5] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway |
070 [1] 70 💬 |
258 |
Diagnostic test: beam test to predict falls |
Tricyclazole |
- |
- |
- |
006 [1] 6 💬 |
259 |
Diagnostic test: biotherapy prescription with sinnotest® software |
- |
- |
- |
- |
046 [1] 46 💬 |
260 |
Diagnostic test: dexamethasone test |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
075 [1] 75 💬 |
261 |
Diagnostic test: fecal microbiome probiotic |
- |
- |
- |
- |
294 [1] 294 💬 |
262 |
Diagnostic test: preoparative blood laboratory tests |
- |
- |
- |
- |
235 [1] 235 💬 |
263 |
Diagnostic test: pressure pain threshold |
- |
- |
- |
- |
113 [1] 113 💬 |
264 |
Diagnostic test: pulmonary microbiome probiotic |
- |
- |
- |
- |
294 [1] 294 💬 |
265 |
Diagnostic test: retrospective evaluation of endoscopy prior to study drug |
- |
- |
- |
- |
098 [1] 98 💬 |
266 |
Diagnostic test: voc probiotic |
- |
- |
- |
- |
294 [1] 294 💬 |
267 |
Diazoxide |
Diazoxide |
[1] D00294 D00294 💬 |
ABCC8 [2] ABCC8, KCNJ11 💬 |
ABC transporters [4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
013 [2] 13, 193 💬 |
268 |
Diazoxide choline |
Choline |
[2] D00294 D00294, D07690 D07690 💬 |
ABCC8 [2] ABCC8, KCNJ11 💬 |
ABC transporters [4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
193 [1] 193 💬 |
269 |
Diazoxide choline controlled-release tablet |
Choline |
[2] D00294 D00294, D07690 D07690 💬 |
ABCC8 [2] ABCC8, KCNJ11 💬 |
ABC transporters [4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
193 [1] 193 💬 |
270 |
Diclofenac + omeprazole |
Diclofenac |
[7] D00455 D00455, D00903 D00903, D00904 D00904, D01207 D01207, D05259 D05259, D05261 D05261, D07816 D07816 💬 |
ATP4A [4] ATP4A, ATP4B, PTGS1, PTGS2 💬 |
Alzheimer disease [26] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
271 |
Dimebon + omeprazole |
Latrepirdine |
[5] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261, D09917 D09917 💬 |
ACHE [8] ACHE, ATP4A, ATP4B, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [26] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Dopaminergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxidative phosphorylation, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 [1] 8 💬 |
272 |
Dopamine agonists (pramipexole, ropirinole) |
Dopamine |
[4] D00559 D00559, D00633 D00633, D05575 D05575, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
273 |
Dose of 60 mg/kg alpha1-proteinase inhibitor |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 [1] 231 💬 |
274 |
Dose of 60 mg/kg fraction iv-1 alpha1-proteinase inhibitor |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 [1] 231 💬 |
275 |
Doxepin |
Doxepin |
[2] D00814 D00814, D07875 D07875 💬 |
HRH1 [3] HRH1, SLC6A2, SLC6A4 💬 |
Calcium signaling pathway [5] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
006 [1] 6 💬 |
276 |
Doxepin and zopiclone |
Doxepin |
[3] D00814 D00814, D01372 D01372, D07875 D07875 💬 |
GABRA1 [19] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, SLC6A2, SLC6A4 💬 |
Calcium signaling pathway [10] Calcium signaling pathway, GABAergic synapse, Inflammatory mediator regulation of TRP channels, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction |
006 [1] 6 💬 |
277 |
Dual release hydrocortisone (plenadren) |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
278 |
Dupilumab prefilled syringe |
Dupilumab |
[1] D10354 D10354 💬 |
IL4R [1] IL4R 💬 |
Cytokine-cytokine receptor interaction [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation |
160 [1] 160 💬 |
279 |
Egg white protein |
Egg |
- |
- |
- |
096 [1] 96 💬 |
280 |
Egg yolk preparation with cholesterol |
Cholesterol |
[1] D00040 D00040 💬 |
- |
- |
310 [1] 310 💬 |
281 |
Eltrombopag |
Eltrombopag |
[1] D03978 D03978 💬 |
- |
- |
060 [5] 60, 63, 65, 284, 285 💬 |
282 |
Eltrombopag (revolade) |
Eltrombopag |
[1] D03978 D03978 💬 |
- |
- |
063 [1] 63 💬 |
283 |
Eltrombopag 12.5 mg |
Eltrombopag |
[1] D03978 D03978 💬 |
- |
- |
060 [1] 60 💬 |
284 |
Eltrombopag 25 mg |
Eltrombopag |
[1] D03978 D03978 💬 |
- |
- |
060 [1] 60 💬 |
285 |
Eltrombopag combining rituximab |
Eltrombopag |
[2] D02994 D02994, D03978 D03978 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
063 [1] 63 💬 |
286 |
Eltrombopag olamine |
Eltrombopag |
[1] D03978 D03978 💬 |
- |
- |
060 [2] 60, 63 💬 |
287 |
Eltrombopag olamine (sb-497115-gr) |
Eltrombopag |
[1] D03978 D03978 💬 |
- |
- |
063 [1] 63 💬 |
288 |
Eltrombopag olamine, revolade, promacta |
Eltrombopag |
[1] D03978 D03978 💬 |
- |
- |
063 [1] 63 💬 |
289 |
Eltrombopag oral tablets |
Eltrombopag |
[1] D03978 D03978 💬 |
- |
- |
063 [1] 63 💬 |
290 |
Enbrel - 50 mg soluzione iniettabile in siringa (vetro da 1 ml) preriempita - uso sottocutaneo 12 siringhe preriempite + 24 tamponi imbevuti di alcol |
- |
- |
- |
- |
046 [1] 46 💬 |
291 |
Enbrel 50 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
046 [1] 46 💬 |
292 |
Enbrel 50mg pre-filled pen |
- |
- |
- |
- |
046 [1] 46 💬 |
293 |
Enbrel 50mg pre-filled syringe |
- |
- |
- |
- |
046 [1] 46 💬 |
294 |
Enbrel pre-filled pen |
- |
- |
- |
- |
046 [1] 46 💬 |
295 |
Enbrel pre-filled syringe |
- |
- |
- |
- |
046 [1] 46 💬 |
296 |
Enbrel® 50 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
046 [1] 46 💬 |
297 |
Engineerd protein inhibitor of human neutrophil elastase |
- |
- |
- |
- |
299 [1] 299 💬 |
298 |
Engineered protein inhibitor of human neutrophil elastase |
- |
- |
- |
- |
299 [1] 299 💬 |
299 |
Ensure high protein |
- |
- |
- |
- |
299 [1] 299 💬 |
300 |
Epinephrine |
Epinephrine |
[3] D00095 D00095, D00996 D00996, D02149 D02149 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [2] 46, 96 💬 |
301 |
Epoprostenol |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
302 |
Epoprostenol for injection |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
303 |
Epoprostenol sodico |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
304 |
Epoprostenol sodium |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
305 |
Epoprostenol-actelion |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
306 |
Erythromycin |
Erythromycin |
[9] D00140 D00140, D00851 D00851, D01361 D01361, D02009 D02009, D02184 D02184, D02523 D02523, D02524 D02524, D02525 D02525, D04054 D04054 💬 |
- |
- |
006 [5] 6 , 36, 164, 228, 291 💬 |
307 |
Erythropoietin |
Erythropoietin |
[1] D03231 D03231 💬 |
EPOR [1] EPOR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [9] 2 , 6 , 13, 18, 22, 47, 70, 95, 96 💬 |
308 |
Erythropoietin human recombinant (eporh) |
Erythropoietin |
[1] D03231 D03231 💬 |
EPOR [1] EPOR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
006 [1] 6 💬 |
309 |
Etanercept pre-filled syringe |
Etanercept |
[1] D00742 D00742 💬 |
LTA [2] LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
310 |
Etanercept pre-filled syringe sq injection |
Etanercept |
[1] D00742 D00742 💬 |
LTA [2] LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
311 |
Etanercept, methotrexate, prednisolone |
Etanercept |
[11] D00142 D00142, D00472 D00472, D00742 D00742, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02115 D02115, D02156 D02156, D03301 D03301 💬 |
DHFR [5] DHFR, DHFR2, LTA, NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [70] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
056 [1] 56 💬 |
312 |
Eus procedure with drug injection |
- |
- |
- |
- |
298 [1] 298 💬 |
313 |
Evaluation of biological predictive factors of clinical response to ustekinumab |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [1] 96 💬 |
314 |
Everolimus oral product |
Everolimus |
[1] D02714 D02714 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
089 [2] 89, 158 💬 |
315 |
Exelon patch (rivastigmine transdermal system) |
Rivastigmine |
[2] D02558 D02558, D03822 D03822 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
316 |
Fampyra - 10 mg - compressa a rilascio prolungato - uso orale - flacone (hdpe) 56 compresse (4 flaconi da 14) |
- |
- |
- |
- |
013 [1] 13 💬 |
317 |
Fampyra 10 mg prolonged-release tablets |
- |
- |
- |
- |
013 [1] 13 💬 |
318 |
Fampyra 10mg prolonged release tablets |
- |
- |
- |
- |
013 [1] 13 💬 |
319 |
Fentanyl (low dose) + dexmedetomidine |
Dexmedetomidine |
[4] D00320 D00320, D00514 D00514, D01205 D01205, D01399 D01399 💬 |
ADRA2A [4] ADRA2A, ADRA2B, ADRA2C, OPRM1 💬 |
Estrogen signaling pathway [4] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
215 [1] 215 💬 |
320 |
Finasteride |
Finasteride |
[1] D00321 D00321 💬 |
SRD5A2 [1] SRD5A2 💬 |
Prostate cancer [2] Prostate cancer, Steroid hormone biosynthesis |
006 [1] 6 💬 |
321 |
Fixed dose combination ciprofloxacin/celecoxib |
Celecoxib |
[3] D00186 D00186, D00567 D00567, D02216 D02216 💬 |
PTGS2 [1] PTGS2 💬 |
Alzheimer disease [22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
002 [1] 2 💬 |
322 |
Fluconazole |
Fluconazole |
[2] D00322 D00322, D01429 D01429 💬 |
- |
- |
096 [2] 96, 225 💬 |
323 |
Fluoxetine |
Fluoxetine |
[2] D00326 D00326, D00823 D00823 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
013 [4] 13, 17, 78, 86 💬 |
324 |
Fluoxetine hydrochloride |
Fluoxetine |
[2] D00326 D00326, D00823 D00823 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
013 [1] 13 💬 |
325 |
Fluticasone propionate |
Fluticasone |
[2] D01708 D01708, D07981 D07981 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [2] 98, 228 💬 |
326 |
Fluticasone propionate, 800 mcg twice daily (post 4fed failure) |
Fluticasone |
[2] D01708 D01708, D07981 D07981 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
327 |
Fluticasone propionate, 880 mcg twice daily (after 6fed failure) |
Fluticasone |
[2] D01708 D01708, D07981 D07981 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
328 |
Fluticasone propionate, usp |
Fluticasone |
[2] D01708 D01708, D07981 D07981 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
329 |
Freshly-pressed extra virgin olive oil |
Olea europaea leaf |
[1] D03311 D03311 💬 |
- |
- |
013 [1] 13 💬 |
330 |
G2-sfm (ifn-beta-1a from clone 484-39,fbs-free process) |
- |
- |
- |
- |
013 [1] 13 💬 |
331 |
Gabapentin prescriptions |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
298 [1] 298 💬 |
332 |
Gadoteridol |
Gadoteridol |
[1] D01137 D01137 💬 |
- |
- |
013 [1] 13 💬 |
333 |
Gadovist 1 mmol/ml solución inyectable en jeringa precargada/ cartucho precargado |
- |
- |
- |
- |
013 [1] 13 💬 |
334 |
Ganaxolone, spt3162, md 9150000, ccd-1042, mepalon 1042, (3a-hydroxy-3beta-methyl-5a-pregnan-20-one) |
Ganaxolone |
[1] D04300 D04300 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
152 [1] 152 💬 |
335 |
Ganaxolone, spt3162, md 9150000, ccd-1042, mepalon 1042, (3a-hydroxy-3ß-methyl-5a-pregnan-20-one) |
Ganaxolone |
[1] D04300 D04300 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
152 [1] 152 💬 |
336 |
Genetic: protein expression analysis |
- |
- |
- |
- |
028 [2] 28, 60 💬 |
337 |
Genetically engineered hematopoietic stem progenitor cells |
- |
- |
- |
- |
285 [1] 285 💬 |
338 |
Genetically engineered hematopoietic stem/progenitor cells |
- |
- |
- |
- |
285 [1] 285 💬 |
339 |
Glucocorticoid (prednisone or prednisolone) |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
084 [1] 84 💬 |
340 |
Glycomacropeptide-based protein substitute |
- |
- |
- |
- |
240 [1] 240 💬 |
341 |
Golimumab final vialed product (fvp) |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
342 |
Golimumab liquid in prefilled pen |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
343 |
Golimumab liquid in prefilled pen or prefilled syringe |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
344 |
Golimumab liquid in prefilled syringe |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [3] 46, 84, 97 💬 |
345 |
Golimumab pre-filled syringe |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [2] 46, 271 💬 |
346 |
Golimumab prefilled pen |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
347 |
Golimumab prefilled pen or prefilled syringe |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
348 |
Golimumab prefilled syringe |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
349 |
Gp2013 - a proposed biosimilar rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
350 |
Granulocyte-colony stimulating factor (g-csf) and prednisone |
Filgrastim |
[2] D00473 D00473, D03235 D03235 💬 |
CSF3R [2] CSF3R, NR3C1 💬 |
Cytokine-cytokine receptor interaction [6] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathways in cancer |
013 [1] 13 💬 |
351 |
Group a sle prospective study |
- |
- |
- |
- |
049 [1] 49 💬 |
352 |
Gsk1605786 gsk modified-process: formulation d |
- |
- |
- |
- |
096 [1] 96 💬 |
353 |
Gvhd prophylaxis |
- |
- |
- |
- |
060 [2] 60, 65 💬 |
354 |
Heparin & alkalinized lidocaine bladder instillation |
Heparin |
[4] D00358 D00358, D02086 D02086, D07510 D07510, D08127 D08127 💬 |
SCN1A [6] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 |
Adrenergic signaling in cardiomyocytes [4] Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction |
226 [1] 226 💬 |
355 |
Hepatitis b virus surface antigen recombinant (s protein) |
- |
- |
- |
- |
046 [1] 46 💬 |
356 |
Heterologous human adult liver-derived progenitor cells |
- |
- |
- |
- |
251 [1] 251 💬 |
357 |
Heterologous human adult liver-derived progenitor cells (hhalpc) |
- |
- |
- |
- |
251 [1] 251 💬 |
358 |
High dose dexamethasone pulses |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
063 [1] 63 💬 |
359 |
High protein high fiber diet |
- |
- |
- |
- |
093 [2] 93, 95 💬 |
360 |
High protein. t-diet plus range |
- |
- |
- |
- |
006 [1] 6 💬 |
361 |
Hormonal profile |
- |
- |
- |
- |
113 [1] 113 💬 |
362 |
Hormone (prednisone) |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
363 |
Hpv prophylactic vaccine gardasil |
- |
- |
- |
- |
049 [1] 49 💬 |
364 |
Human anti-promyostatin monoclonal antibody |
- |
- |
- |
- |
003 [1] 3 💬 |
365 |
Human glucocerebrosidase (prgcd) |
Taliglucerase alfa |
[1] D09675 D09675 💬 |
GBA [1] GBA 💬 |
Lysosome [4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 [1] 19 💬 |
366 |
Human monoclonal antibody directed against complement 5 protein |
- |
- |
- |
- |
062 [1] 62 💬 |
367 |
Human primary retinal pigment epithelial (hurpe) cells |
- |
- |
- |
- |
090 [1] 90 💬 |
368 |
Human recombinant tissue non-specific alkaline phosphatase fusion protein |
Alkaline Phosphatase |
- |
- |
- |
172 [1] 172 💬 |
369 |
Human retinal progenitor cells |
- |
- |
- |
- |
090 [1] 90 💬 |
370 |
Human retinal progenitor cells drug product |
- |
- |
- |
- |
090 [1] 90 💬 |
371 |
Humira 20 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
096 [1] 96 💬 |
372 |
Humira 40 mg injekcní roztok v predplnené injekcní stríkacce |
- |
- |
- |
- |
096 [1] 96 💬 |
373 |
Humira 40 mg solución inyectable en jeringa precargada |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
374 |
Humira 40 mg solution for injection in pre-filled pen |
- |
- |
- |
- |
096 [1] 96 💬 |
375 |
Humira 40 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
376 |
Humira 40 mg solution for injection in pre-filled syringes |
- |
- |
- |
- |
097 [1] 97 💬 |
377 |
Humira 40mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
046 [1] 46 💬 |
378 |
Humira 40mg solution for injection in pre-filled syringe (adalimumab) |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
379 |
Humira 40mg/0.4ml pre-filled syringe |
- |
- |
- |
- |
096 [1] 96 💬 |
380 |
Humira 40mg/0.8ml solution for injection in pre-filled syringe |
- |
- |
- |
- |
046 [1] 46 💬 |
381 |
Humira pre-filled pen |
- |
- |
- |
- |
096 [1] 96 💬 |
382 |
Humira ® (adalimumab) 40mg/0.8ml pre-filled syringe |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
383 |
Humira, 40 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
046 [1] 46 💬 |
384 |
Humira® 40 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
046 [1] 46 💬 |
385 |
Humira® 40 mg/ 0.8 ml solution for injection in pre-filled syringe |
- |
- |
- |
- |
046 [1] 46 💬 |
386 |
Hydrocortisone |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [9] 6 , 46, 53, 75, 78, 81, 83, 97, 299 💬 |
387 |
Hydrocortisone (solucortef) |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
388 |
Hydrocortisone 100mg/ml |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
083 [1] 83 💬 |
389 |
Hydrocortisone 10mg |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
390 |
Hydrocortisone 10mg tablet |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
391 |
Hydrocortisone 10mg tablets |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
392 |
Hydrocortisone 20mg tablets |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
393 |
Hydrocortisone acetate |
Acetate |
[2] D00088 D00088, D00165 D00165 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
394 |
Hydrocortisone cream |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
395 |
Hydrocortisone cream 1% |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
396 |
Hydrocortisone cream 10mg/g fna fagron |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
397 |
Hydrocortisone hydrogen succinate |
Hydrocortisone |
[2] D00088 D00088, D01442 D01442 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
083 [1] 83 💬 |
398 |
Hydrocortisone modified release capsules |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
399 |
Hydrocortisone roussel |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
083 [1] 83 💬 |
400 |
Hydrocortisone sodium acetate |
Acetate |
[2] D00088 D00088, D01779 D01779 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
401 |
Hydrocortisone sodium phosphate |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
053 [3] 53, 81, 83 💬 |
402 |
Hydrocortisone sodium succinate |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [3] 81, 83, 97 💬 |
403 |
Hydrocortisone tablet 2.5 mg |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
404 |
Hydrocortisone takeda, tabletter |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
078 [1] 78 💬 |
405 |
Hydroxychloroquine + prednisone |
Hydroxychloroquine |
[2] D00473 D00473, D08050 D08050 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
084 [1] 84 💬 |
406 |
Imd preparative regimen |
- |
- |
- |
- |
019 [5] 19, 20, 125, 234, 326 💬 |
407 |
Immunoglobulin g1, anti (protein nogo a) (human mus musculus monoclonal heavy |
- |
- |
- |
- |
002 [1] 2 💬 |
408 |
Immunoglobulin g1, anti (protein nogo a) (human mus musculus monoclonal heavy chain), disulfide with human mus musculus monoclonal light chain, dimer |
- |
- |
- |
- |
002 [1] 2 💬 |
409 |
Inactive reminder product |
- |
- |
- |
- |
019 [1] 19 💬 |
410 |
Inflammatory profile |
- |
- |
- |
- |
113 [1] 113 💬 |
411 |
Inhaled prostacyclin |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
412 |
Inn not yet proposed |
- |
- |
- |
- |
193 [1] 193 💬 |
413 |
Interferon beta-1a (current approved manufacturing process invloving fbs) |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
414 |
Interferon beta-1a (new process, manufactured without fbs) |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
415 |
Interferon beta-1b and tacrolimus |
Human interferon beta |
[3] D00107 D00107, D00746 D00746, D08556 D08556 💬 |
IFNAR1 [7] IFNAR1, IFNAR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [47] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Epstein-Barr virus infection, Glucagon signaling pathway, Glutamatergic synapse, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
416 |
Interleukin-2 (aldesleukin). |
Aldesleukin |
[1] D00748 D00748 💬 |
IL2RA [3] IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction [14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
096 [2] 96, 97 💬 |
417 |
Intervention for incipient patients at low risk of disease progression |
- |
- |
- |
- |
066 [1] 66 💬 |
418 |
Intervention for patients at high risk of disease progression |
- |
- |
- |
- |
066 [1] 66 💬 |
419 |
Intra plexus triamcinolone and bupivicaine injection |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
298 [1] 298 💬 |
420 |
Intra-articular compound betamethasone |
Betamethasone |
[7] D00244 D00244, D00972 D00972, D01357 D01357, D01402 D01402, D01637 D01637, D02032 D02032, D02286 D02286 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
421 |
Intraarticular betamethasone |
Betamethasone |
[7] D00244 D00244, D00972 D00972, D01357 D01357, D01402 D01402, D01637 D01637, D02032 D02032, D02286 D02286 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
422 |
Intraarticular dexamethasone |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
423 |
Intravenous dexamethasone 1 mg |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
424 |
Intravenous methyl prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
043 [1] 43 💬 |
425 |
Intubated with propofol (ip) |
Propofol |
[1] D00549 D00549 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
098 [1] 98 💬 |
426 |
Ir prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
427 |
Ivacaftor (proposed inn) |
Ivacaftor |
[1] D09916 D09916 💬 |
CFTR [1] CFTR 💬 |
ABC transporters [8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway |
299 [1] 299 💬 |
428 |
Kenalog injectable product |
- |
- |
- |
- |
070 [1] 70 💬 |
429 |
Kinoquinone (proposed) |
- |
- |
- |
- |
006 [1] 6 💬 |
430 |
L-lysyl-d-prolyl-l-threonine acetate |
Acetate |
[1] D00041 D00041 💬 |
- |
- |
097 [1] 97 💬 |
431 |
L-lysyl-d-prolyl-lthreonine acetate, lyophilisate |
Acetate |
- |
- |
- |
097 [1] 97 💬 |
432 |
L01xe - protein kinase inhibitors |
- |
- |
- |
- |
085 [1] 85 💬 |
433 |
Lactic acid producing organisms |
Lactic acid |
[1] D00111 D00111 💬 |
- |
- |
299 [1] 299 💬 |
434 |
Lamotrigine - generic product |
Lamotrigine |
[1] D00354 D00354 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
038 [1] 38 💬 |
435 |
Lansoprazole |
Lansoprazole |
[1] D00355 D00355 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
063 [7] 63, 71, 85, 98, 166, 222, 299 💬 |
436 |
Lansoprazole 30mg |
Lansoprazole |
[1] D00355 D00355 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
166 [1] 166 💬 |
437 |
Lansoprazole, amoxicillin, clarithromycin |
Amoxicillin |
[5] D00229 D00229, D00276 D00276, D00355 D00355, D02925 D02925, D07452 D07452 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
222 [1] 222 💬 |
438 |
Lansoprazole, clarithromycin, amoxycillin |
Amoxicillin |
[5] D00229 D00229, D00276 D00276, D00355 D00355, D02925 D02925, D07452 D07452 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
063 [1] 63 💬 |
439 |
Lantus® 100 units/ml solution for injection in a vial. lantus® 100 units/ml solution for injection in a cartridge. lantus® 100 units/ml solution for injection in a pre-filled pen |
- |
- |
- |
- |
299 [1] 299 💬 |
440 |
Lap tap bupivacaine/epinephrine |
Bupivacaine |
[5] D00095 D00095, D00996 D00996, D01450 D01450, D02149 D02149, D07552 D07552 💬 |
ADRA1A [14] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [15] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [1] 96 💬 |
441 |
Large protein molecule |
- |
- |
- |
- |
046 [1] 46 💬 |
442 |
Lcp-tacro (tacrolimus) |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
095 [1] 95 💬 |
443 |
Leflunomide 20 mg+prednisone 0.5mg/kg/d |
Leflunomide |
[2] D00473 D00473, D00749 D00749 💬 |
DHODH [2] DHODH, NR3C1 💬 |
Biosynthesis of cofactors [4] Biosynthesis of cofactors, Metabolic pathways, Neuroactive ligand-receptor interaction, Pyrimidine metabolism |
066 [1] 66 💬 |
444 |
Lenalidomide and dexamethasone |
Dexamethasone |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D04687 D04687 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
016 [1] 16 💬 |
445 |
Lenalidomide+dexamethasone |
Dexamethasone |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D04687 D04687 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
016 [1] 16 💬 |
446 |
Lenalidomide, dexamethasone |
Dexamethasone |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D04687 D04687 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
016 [1] 16 💬 |
447 |
Lenalidomide, dexamethasone and cyclophosphamide |
Cyclophosphamide |
[12] D00287 D00287, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D04687 D04687, D07760 D07760 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 [1] 28 💬 |
448 |
Lenti-d drug product |
- |
- |
- |
- |
020 [1] 20 💬 |
449 |
Letrozole |
Letrozole |
[1] D00964 D00964 💬 |
CYP19A1 [1] CYP19A1 💬 |
Metabolic pathways [3] Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis |
081 [2] 81, 89 💬 |
450 |
Levemir 100 u/ml solution for injection in a cartridge, levemir 100 u/ml solution for injection in a pre-filled pen |
- |
- |
- |
- |
299 [1] 299 💬 |
451 |
Levocarnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
003 [3] 3 , 53, 97 💬 |
452 |
Levocarnitine propyl hydrochloride |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
097 [1] 97 💬 |
453 |
Licorice |
Licorice |
[1] D04365 D04365 💬 |
- |
- |
053 [1] 53 💬 |
454 |
Lidocaine |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 [10] 6 , 13, 34, 46, 51, 86, 168, 226, 231, 256 💬 |
455 |
Lidocaine 1% injectable solution |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
034 [1] 34 💬 |
456 |
Lidocaine 2% without vessel constrictor |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
051 [1] 51 💬 |
457 |
Lidocaine injection 2% |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
168 [1] 168 💬 |
458 |
Lidocaine patch 5% |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 [1] 13 💬 |
459 |
Lidocaine releasing intravesical system - liris® |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
226 [1] 226 💬 |
460 |
Lisinopril |
Lisinopril |
[2] D00362 D00362, D08131 D08131 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
019 [7] 19, 46, 49, 66, 67, 113, 222 💬 |
461 |
Lisinopril pills |
Lisinopril |
[2] D00362 D00362, D08131 D08131 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
049 [1] 49 💬 |
462 |
Lisinopril, losartan, and atorvastatin |
Atorvastatin |
[7] D00258 D00258, D00357 D00357, D00362 D00362, D00887 D00887, D07474 D07474, D08131 D08131, D08146 D08146 💬 |
ACE [3] ACE, AGTR1, HMGCR 💬 |
AGE-RAGE signaling pathway in diabetic complications [22] AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
222 [1] 222 💬 |
463 |
Local anesthesia (lidocaine hydrochloride) |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 [1] 6 💬 |
464 |
Lodotra (delayed release prednisolone) |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
041 [1] 41 💬 |
465 |
Lonafarnib, zoledronic acid, and pravastatin |
Lonafarnib |
[7] D00893 D00893, D01968 D01968, D04768 D04768, D06378 D06378, D06379 D06379, D08410 D08410, D08689 D08689 💬 |
FDPS [4] FDPS, FNTA, FNTB, HMGCR 💬 |
AMPK signaling pathway [6] AMPK signaling pathway, Bile secretion, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
333 [1] 333 💬 |
466 |
Long term follow up in all patients who received sar422459 in previous study tdu13583 |
- |
- |
- |
- |
301 [1] 301 💬 |
467 |
Long-circulating liposomal prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
468 |
Losartan and atenolol or propranolol |
Atenolol |
[5] D00235 D00235, D00357 D00357, D00483 D00483, D08146 D08146, D08443 D08443 💬 |
ADRB1 [4] ADRB1, ADRB2, ADRB3, AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [22] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
167 [1] 167 💬 |
469 |
Low calorie protein substitute |
- |
- |
- |
- |
240 [1] 240 💬 |
470 |
Low dose prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
084 [1] 84 💬 |
471 |
Low-dose aldesleukin (proleukin®) |
Aldesleukin |
[1] D00748 D00748 💬 |
IL2RA [3] IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction [14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
049 [1] 49 💬 |
472 |
Lysine-d-proline-threonine |
D-Proline |
[3] D00035 D00035, D00041 D00041, D02304 D02304 💬 |
- |
- |
097 [1] 97 💬 |
473 |
Mabthera or biosimilar rituximab product |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
474 |
Medium dose prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
084 [1] 84 💬 |
475 |
Melatonin pr |
Melatonin |
[1] D08170 D08170 💬 |
MTNR1A [2] MTNR1A, MTNR1B 💬 |
Circadian entrainment [2] Circadian entrainment, Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
476 |
Melphalan, thalidomide and dexamethasone |
Dexamethasone |
[11] D00292 D00292, D00369 D00369, D00754 D00754, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 [1] 28 💬 |
477 |
Mesalazine with hydrocortisone sodium succinate |
Hydrocortisone |
[2] D00088 D00088, D00377 D00377 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
478 |
Mesencephalic neuronal precursor cells |
- |
- |
- |
- |
006 [1] 6 💬 |
479 |
Metabolic profile |
- |
- |
- |
- |
113 [1] 113 💬 |
480 |
Methotrexate (metoject® prefilled pen) |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
481 |
Methotrexate - etanercept - prednisolone arm |
Etanercept |
[11] D00142 D00142, D00472 D00472, D00742 D00742, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02115 D02115, D02156 D02156, D03301 D03301 💬 |
DHFR [5] DHFR, DHFR2, LTA, NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [70] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
482 |
Methotrexate 50mg/ml solution for injection, pre-filled syringe |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
483 |
Methotrexate pre-filled pen |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
484 |
Methotrexate prefilled pen |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
485 |
Methotrexate prefilled syringe |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
486 |
Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
487 |
Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol. |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
488 |
Methyl prednisolonate |
- |
- |
- |
- |
013 [1] 13 💬 |
489 |
Methyl prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
043 [3] 43, 49, 96 💬 |
490 |
Methylene blue |
Methylene blue |
[2] D02312 D02312, D10537 D10537 💬 |
- |
- |
097 [1] 97 💬 |
491 |
Methylene blue 25mg tablets |
Methylene blue |
[2] D02312 D02312, D10537 D10537 💬 |
- |
- |
097 [1] 97 💬 |
492 |
Methylprednisolone (mp) or prednisone (pred) |
Methylprednisolone |
[7] D00407 D00407, D00473 D00473, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
493 |
Methylprednisolone or prednisolone |
Methylprednisolone |
[14] D00407 D00407, D00472 D00472, D00751 D00751, D00979 D00979, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
065 [1] 65 💬 |
494 |
Metoclopramide |
Metoclopramide |
[3] D00726 D00726, D02213 D02213, D05008 D05008 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
051 [1] 51 💬 |
495 |
Metoclopramide accord - 10 mg compresse 28 compresse in blister pvc/pvdc/al |
Metoclopramide |
[3] D00726 D00726, D02213 D02213, D05008 D05008 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
051 [1] 51 💬 |
496 |
Metoject 10 mg/ml, solution injectable en seringue pré-remplie |
- |
- |
- |
- |
044 [1] 44 💬 |
497 |
Mezavant gastro-resistant, prolonged release tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
498 |
Mezavant xl 1200 mg gastro-resistant prolonged release tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
499 |
Mezavant xl 1200 mg gastro-resistant, prolonged release tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
500 |
Mezavant xl 1200 mg gastro-resistant, prolonged release tablets. |
- |
- |
- |
- |
097 [1] 97 💬 |
501 |
Mezavant xl 1200mg gastro-resistant, prolonged release tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
502 |
Mezavant xl gastro-resistant, prolonged release tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
503 |
Midodrine |
Midodrine |
[2] D01307 D01307, D08220 D08220 💬 |
ADRA1A [3] ADRA1A, ADRA1B, ADRA1D 💬 |
AMPK signaling pathway [7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
006 [3] 6 , 17, 58 💬 |
504 |
Midodrine hydrochloride |
Midodrine |
[2] D01307 D01307, D08220 D08220 💬 |
ADRA1A [3] ADRA1A, ADRA1B, ADRA1D 💬 |
AMPK signaling pathway [7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 [1] 58 💬 |
505 |
Milrinone |
Milrinone |
[2] D00417 D00417, D02085 D02085 💬 |
PDE3A [2] PDE3A, PDE3B 💬 |
Apelin signaling pathway [11] Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
294 [1] 294 💬 |
506 |
Mirapex (pramipexole) |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
507 |
Mmf and dexamethasone |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
222 [1] 222 💬 |
508 |
Mobilization of stem cells to prepare for leukapheresis |
- |
- |
- |
- |
096 [1] 96 💬 |
509 |
Modafinil |
Modafinil |
[1] D01832 D01832 💬 |
- |
- |
006 [4] 6 , 13, 49, 93 💬 |
510 |
Modafinil 50mg |
Modafinil |
[1] D01832 D01832 💬 |
- |
- |
006 [1] 6 💬 |
511 |
Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142 |
BMS-986142 |
[11] D00298 D00298, D00330 D00330, D00529 D00529, D00550 D00550, D00696 D00696, D00893 D00893, D01475 D01475, D02290 D02290, D05028 D05028, D08229 D08229, D08410 D08410 💬 |
ATP1A1 [24] ATP1A1, ATP1A2, ATP1A3, ATP1A4, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HMGCR, PTGS1, PTGS2 💬 |
AMPK signaling pathway [49] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Terpenoid backbone biosynthesis, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
512 |
Moss-agal (recombinant human alpha-galactosidase a produced in moss) |
Agalsidase alfa |
[1] D02784 D02784 💬 |
GLA [1] GLA 💬 |
Galactose metabolism [6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 [1] 19 💬 |
513 |
Mr prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
514 |
Multienzymes (lipase, protease etc.) |
- |
- |
- |
- |
298 [2] 298, 299 💬 |
515 |
Mupirocin |
Mupirocin |
[2] D01076 D01076, D02195 D02195 💬 |
- |
- |
227 [2] 227, 299 💬 |
516 |
Mupirocin intranasal creme |
Mupirocin |
[2] D01076 D01076, D02195 D02195 💬 |
- |
- |
299 [1] 299 💬 |
517 |
Mycophenolate mofetil plus lower dose of prednisone |
Mycophenolate mofetil |
[5] D00473 D00473, D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [3] IMPDH1, IMPDH2, NR3C1 💬 |
Drug metabolism - other enzymes [4] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism |
066 [1] 66 💬 |
518 |
Myeloablative preparative regimen |
- |
- |
- |
- |
062 [3] 62, 65, 284 💬 |
519 |
Myelostim - 34 1 flaconcino liofilizzato 33.6 miu + siringa preriempita solvente 1 ml |
- |
- |
- |
- |
019 [2] 19, 65 💬 |
520 |
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine |
- |
- |
- |
- |
013 [1] 13 💬 |
521 |
Naproxen 500 mg tablets (pn 200 minus omeprazole) |
Naproxen |
[5] D00118 D00118, D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [4] ATP4A, ATP4B, PTGS1, PTGS2 💬 |
Alzheimer disease [26] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [2] 46, 271 💬 |
522 |
Nebido® testosterone undecanoate 1000 mg/4 ml solution for injection |
Testosterone |
[6] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
013 [1] 13 💬 |
523 |
Nebulized combination ipratropium bromide with salbutamol |
Ipratropium |
[2] D02147 D02147, D02212 D02212 💬 |
ADRB2 [6] ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Adrenergic signaling in cardiomyocytes [17] Adrenergic signaling in cardiomyocytes, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
524 |
New thermo stable formulation of epoprostenol sodium |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
525 |
Nifedipine |
Nifedipine |
[1] D00437 D00437 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
050 [2] 50, 81 💬 |
526 |
Non propietry, therefore n/a |
- |
- |
- |
- |
051 [1] 51 💬 |
527 |
Novorapid 100 u/ml, solution for injection in a vial. novorapid penfill 100 u/ml, solution for injection in a cartridge. novorapid flexpen 100 u/ml, solution for injection in a pre-filled pen. |
- |
- |
- |
- |
299 [1] 299 💬 |
528 |
Nusinersen injectable product |
Nusinersen |
[1] D10881 D10881 💬 |
SMN2 [1] SMN2 💬 |
RNA transport [1] RNA transport |
003 [1] 3 💬 |
529 |
Omega 3 premium |
- |
- |
- |
- |
299 [1] 299 💬 |
530 |
Omeprazole |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 [16] 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
531 |
Omeprazole (uk licensed generic product) |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
085 [1] 85 💬 |
532 |
Omeprazole 20 mg |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
096 [2] 96, 97 💬 |
533 |
Omeprazole 20mg |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
051 [1] 51 💬 |
534 |
Omeprazole 20mg bid |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
098 [1] 98 💬 |
535 |
Omeprazole 40 mg |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
096 [1] 96 💬 |
536 |
Omeprazole 40mg capsule |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
299 [1] 299 💬 |
537 |
Omeprazole magnesium |
Magnesium |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
225 [1] 225 💬 |
538 |
Omeprazole rectally 1mg/kg |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
294 [1] 294 💬 |
539 |
Oms721 drug product 185 mg/ml |
- |
- |
- |
- |
109 [1] 109 💬 |
540 |
Only medicinal products registered in austria will be used in this clinical trial. |
- |
- |
- |
- |
078 [1] 78 💬 |
541 |
Only medicinal products registered in germany will be used in this clinical trial |
- |
- |
- |
- |
078 [1] 78 💬 |
542 |
Oral ciprofloxacin |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
543 |
Oral ciprofloxacin plus inhaled colistin |
Ciprofloxacin |
[4] D00186 D00186, D02138 D02138, D02216 D02216, D07746 D07746 💬 |
- |
- |
299 [1] 299 💬 |
544 |
Oral erythromycin |
Erythromycin |
[9] D00140 D00140, D00851 D00851, D01361 D01361, D02009 D02009, D02184 D02184, D02523 D02523, D02524 D02524, D02525 D02525, D04054 D04054 💬 |
- |
- |
036 [1] 36 💬 |
545 |
Oral prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [2] 49, 145 💬 |
546 |
Oral prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
251 [1] 251 💬 |
547 |
Oral prednisone 5mg |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [1] 49 💬 |
548 |
Oral probiotic |
- |
- |
- |
- |
291 [1] 291 💬 |
549 |
Orencia 125 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
046 [3] 46, 49, 53 💬 |
550 |
Orencia 125 mg, solution injectable en seringue préremplie |
- |
- |
- |
- |
046 [1] 46 💬 |
551 |
Orencia® 125 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
065 [1] 65 💬 |
552 |
Osteopetrosis haploidentical only preparative regimen |
- |
- |
- |
- |
019 [5] 19, 20, 125, 234, 326 💬 |
553 |
Osteopetrosis only preparative regimen |
- |
- |
- |
- |
019 [5] 19, 20, 125, 234, 326 💬 |
554 |
Other respiratory system products |
- |
- |
- |
- |
299 [1] 299 💬 |
555 |
Other: a-step (new protocol) |
- |
- |
- |
- |
299 [1] 299 💬 |
556 |
Other: best practice |
- |
- |
- |
- |
060 [1] 60 💬 |
557 |
Other: classic, progressive endurance training |
- |
- |
- |
- |
013 [1] 13 💬 |
558 |
Other: controls primary cervical dystonia (trihexyphenidyl) |
Trihexyphenidyl |
[2] D00787 D00787, D08638 D08638 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [1] 6 💬 |
559 |
Other: empiric use of calcium carbonate and calcitriol |
Calcitriol |
[3] D00129 D00129, D00932 D00932, D10802 D10802 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 [1] 235 💬 |
560 |
Other: eus procedure |
- |
- |
- |
- |
298 [1] 298 💬 |
561 |
Other: glucose profile for 2 weeks |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
562 |
Other: high energy / protein diet. |
- |
- |
- |
- |
096 [1] 96 💬 |
563 |
Other: histone acetylation profiles of cells of srt patients with crebbp mutations |
- |
- |
- |
- |
102 [1] 102 💬 |
564 |
Other: hydrocortisone |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
075 [1] 75 💬 |
565 |
Other: imitation surgical procedure (isp) |
- |
- |
- |
- |
006 [1] 6 💬 |
566 |
Other: low blood pressure control |
- |
- |
- |
- |
067 [1] 67 💬 |
567 |
Other: plasticity-based computerized cognitive remediation program |
- |
- |
- |
- |
013 [1] 13 💬 |
568 |
Other: prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
569 |
Other: pretreatment antibiotics |
- |
- |
- |
- |
097 [1] 97 💬 |
570 |
Other: progressive exercise |
- |
- |
- |
- |
013 [1] 13 💬 |
571 |
Other: propensity score |
- |
- |
- |
- |
013 [1] 13 💬 |
572 |
Other: prospective observational registry |
- |
- |
- |
- |
003 [1] 3 💬 |
573 |
Other: pth based calcium carbonate and calcitriol repletion |
Calcitriol |
[3] D00129 D00129, D00932 D00932, D10802 D10802 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 [1] 235 💬 |
574 |
Other: pulmonary rehabilitation program |
- |
- |
- |
- |
085 [1] 85 💬 |
575 |
Other: refered to general practice |
- |
- |
- |
- |
046 [1] 46 💬 |
576 |
Other: resistance exercise program |
- |
- |
- |
- |
046 [1] 46 💬 |
577 |
Other: salbutamol nebulisation and with cpap |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
228 [1] 228 💬 |
578 |
Other: screening to prevent falls |
- |
- |
- |
- |
006 [1] 6 💬 |
579 |
Other: sham procedure |
- |
- |
- |
- |
090 [1] 90 💬 |
580 |
Other: sham-procedure (dose cohort 1&2 only) |
- |
- |
- |
- |
090 [2] 90, 303 💬 |
581 |
Other: specifically design 6 month resistance training program |
- |
- |
- |
- |
013 [1] 13 💬 |
582 |
Other: standard blood pressure control |
- |
- |
- |
- |
067 [1] 67 💬 |
583 |
Other: standard treatment according to the clinical protocols |
- |
- |
- |
- |
049 [1] 49 💬 |
584 |
Other: water prescription |
Water |
[1] D00001 D00001 💬 |
- |
- |
067 [1] 67 💬 |
585 |
Over encapsulated prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
041 [1] 41 💬 |
586 |
Over-encapsulated modafinil |
Modafinil |
[1] D01832 D01832 💬 |
- |
- |
006 [1] 6 💬 |
587 |
Overencapsulated prednisolone tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
588 |
Oxn 10 mg / 5 mg pr |
- |
- |
- |
- |
006 [1] 6 💬 |
589 |
Oxn 10/5 mg pr |
- |
- |
- |
- |
226 [1] 226 💬 |
590 |
Oxn 20 mg / 10 mg pr |
- |
- |
- |
- |
006 [1] 6 💬 |
591 |
Oxn 20/10 mg pr |
- |
- |
- |
- |
226 [1] 226 💬 |
592 |
Oxn 5 mg/2.5 mg pr |
- |
- |
- |
- |
006 [1] 6 💬 |
593 |
Oxn 5/2.5 mg pr |
- |
- |
- |
- |
226 [1] 226 💬 |
594 |
Oxycodone naloxone prolonged release tablets |
Naloxone |
[5] D01340 D01340, D03783 D03783, D05312 D05312, D05462 D05462, D08249 D08249 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
226 [1] 226 💬 |
595 |
Oxycodone/naloxone prolonged release t |
Naloxone |
[5] D01340 D01340, D03783 D03783, D05312 D05312, D05462 D05462, D08249 D08249 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
226 [1] 226 💬 |
596 |
Oxycodone/naloxone prolonged release tablets |
Naloxone |
[5] D01340 D01340, D03783 D03783, D05312 D05312, D05462 D05462, D08249 D08249 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
597 |
Oxycodone/naloxone prolonged release tablets 10 mg /5 mg |
Naloxone |
[5] D01340 D01340, D03783 D03783, D05312 D05312, D05462 D05462, D08249 D08249 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
598 |
Oxycodone/naloxone prolonged release tablets 10/5 mg |
Naloxone |
[5] D01340 D01340, D03783 D03783, D05312 D05312, D05462 D05462, D08249 D08249 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
226 [1] 226 💬 |
599 |
Oxycodone/naloxone prolonged release tablets 20 mg /10 mg |
Naloxone |
[5] D01340 D01340, D03783 D03783, D05312 D05312, D05462 D05462, D08249 D08249 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
600 |
Oxycodone/naloxone prolonged release tablets 20/10 mg |
Naloxone |
[5] D01340 D01340, D03783 D03783, D05312 D05312, D05462 D05462, D08249 D08249 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
226 [1] 226 💬 |
601 |
Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg |
Naloxone |
[5] D01340 D01340, D03783 D03783, D05312 D05312, D05462 D05462, D08249 D08249 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
602 |
Oxycodone/naloxone prolonged release tablets 5/2.5 mg |
Naloxone |
[5] D01340 D01340, D03783 D03783, D05312 D05312, D05462 D05462, D08249 D08249 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
226 [1] 226 💬 |
603 |
P2b001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg), |
Pramipexole |
[5] D00559 D00559, D02562 D02562, D05575 D05575, D08469 D08469, D10829 D10829 💬 |
DRD2 [4] DRD2, DRD3, DRD4, MAOB 💬 |
Alcoholism [18] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
604 |
P2b001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg), |
Pramipexole |
[5] D00559 D00559, D02562 D02562, D05575 D05575, D08469 D08469, D10829 D10829 💬 |
DRD2 [4] DRD2, DRD3, DRD4, MAOB 💬 |
Alcoholism [18] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
605 |
Pantoprazole |
Pantoprazole |
[2] D02593 D02593, D05353 D05353 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
013 [2] 13, 65 💬 |
606 |
Paroxetine & prednisolone |
Paroxetine |
[12] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02260 D02260, D02362 D02362, D03301 D03301, D05374 D05374, D05375 D05375 💬 |
NR3C1 [2] NR3C1, SLC6A4 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
046 [1] 46 💬 |
607 |
Paroxetine hydrochloride 10 & 20 mg and prednisolone 1 mg bp |
Paroxetine |
[12] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02260 D02260, D02362 D02362, D03301 D03301, D05374 D05374, D05375 D05375 💬 |
NR3C1 [2] NR3C1, SLC6A4 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
046 [1] 46 💬 |
608 |
Paroxetine hydrochloride tablets 10 & 20 mg and prednisolone 1 mg bp |
Paroxetine |
[12] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02260 D02260, D02362 D02362, D03301 D03301, D05374 D05374, D05375 D05375 💬 |
NR3C1 [2] NR3C1, SLC6A4 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
046 [1] 46 💬 |
609 |
Peg-liposomal prednisolone sodium phosphate |
Phosphate ion |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [2] 13, 97 💬 |
610 |
Pentasa 2g sachet prolonged release granules (95%) |
- |
- |
- |
- |
097 [1] 97 💬 |
611 |
Pentasa compact 2g, granulate with prolonged release |
- |
- |
- |
- |
097 [1] 97 💬 |
612 |
Pentasa compact 4g, granulate with prolonged release |
- |
- |
- |
- |
097 [1] 97 💬 |
613 |
Pentasa prolonged release granules 2g |
- |
- |
- |
- |
097 [1] 97 💬 |
614 |
Pentasa sachet 1 g prolonged release granules |
- |
- |
- |
- |
096 [1] 96 💬 |
615 |
Peptidic+probiotic |
- |
- |
- |
- |
096 [1] 96 💬 |
616 |
Peri-neural dexamethasone 1 mg |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
617 |
Ph. eur.: (2s)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid |
Propanoic acid |
[1] D02310 D02310 💬 |
- |
- |
006 [1] 6 💬 |
618 |
Phenylalanine-free protein substitute in tablet form (xphe minis) |
Phenylalanine |
[1] D00021 D00021 💬 |
- |
- |
240 [1] 240 💬 |
619 |
Phenylalanine-free protein substitute tablets |
Phenylalanine |
[1] D00021 D00021 💬 |
- |
- |
240 [1] 240 💬 |
620 |
Pheur.: (2s)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid |
Propanoic acid |
[1] D02310 D02310 💬 |
- |
- |
006 [1] 6 💬 |
621 |
Phosphate and betamethasone acetate, 2 ml. |
Acetate |
[7] D00244 D00244, D00972 D00972, D01357 D01357, D01402 D01402, D01637 D01637, D02032 D02032, D02286 D02286 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
235 [1] 235 💬 |
622 |
Piperacillin-tazobactam combination product |
Piperacillin |
[4] D00466 D00466, D00660 D00660, D02251 D02251, D08380 D08380 💬 |
- |
- |
299 [1] 299 💬 |
623 |
Pla-pru-pla-pru |
- |
- |
- |
- |
099 [1] 99 💬 |
624 |
Pla-pru-pru-pla |
- |
- |
- |
- |
099 [1] 99 💬 |
625 |
Plant cell expressed recombinant glucocerebrosidase (prgcd) |
Taliglucerase alfa |
[1] D09675 D09675 💬 |
GBA [1] GBA 💬 |
Lysosome [4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 [1] 19 💬 |
626 |
Plasma rico en plaquetas y coagulo de fibrina procesados mediante la tecnología prgf-system (bti) |
- |
- |
- |
- |
096 [1] 96 💬 |
627 |
Plegridy - 125 mcg - soluzione iniettabile - uso sottocutaneo - penna preriempita - 0,5 ml - 6 penne preriempite |
- |
- |
- |
- |
013 [1] 13 💬 |
628 |
Pn 200 tablets (500 mg naproxen and 20 mg omeprazole) |
Naproxen |
[5] D00118 D00118, D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [4] ATP4A, ATP4B, PTGS1, PTGS2 💬 |
Alzheimer disease [26] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [2] 46, 271 💬 |
629 |
Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) conjugated to crm197 carrier protein and adsorbed on aluminium phosphate |
Aluminium |
- |
- |
- |
046 [1] 46 💬 |
630 |
Po ciprofloxacin |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
631 |
Polaprezinc |
Polaprezinc |
[1] D01611 D01611 💬 |
- |
- |
096 [2] 96, 97 💬 |
632 |
Poly(oxy-1,2-ethanediyl), alpha-hydro-omega-methoxy, ether with n-[[[2-[[6-[[1-[3-[[3-(2,3-dihydroxypropoxy)propyl]amino]-3-oxopropyl]-2,5-dioxo-3-pyrrolidinyl]thio]hexyl]amino]ethyl]amino]carbonyl]-2-methylalanyl-teriparatide (2:1) |
Diethyl ether |
[2] D01772 D01772, D06078 D06078 💬 |
PTH1R [1] PTH1R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 [1] 235 💬 |
633 |
Pomalidomide and dexamethasone |
Dexamethasone |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D08976 D08976 💬 |
IL6 [3] IL6, NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [79] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 [1] 28 💬 |
634 |
Pomalidomide oral product |
Pomalidomide |
[1] D08976 D08976 💬 |
IL6 [2] IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [78] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
227 [1] 227 💬 |
635 |
Pr |
- |
- |
- |
- |
041 [1] 41 💬 |
636 |
Pr oxycodone |
Oxycodone |
[3] D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
637 |
Pr-06410293 |
- |
- |
- |
- |
046 [1] 46 💬 |
638 |
Pr001 |
- |
- |
- |
- |
019 [1] 19 💬 |
639 |
Pr001a |
- |
- |
- |
- |
006 [1] 6 💬 |
640 |
Pr006 |
- |
- |
- |
- |
127 [1] 127 💬 |
641 |
Pr1 |
- |
- |
- |
- |
051 [1] 51 💬 |
642 |
Pralia 60 mg subcutaneous injection syringe(denosumab) |
Denosumab |
[1] D03684 D03684 💬 |
TNFSF11 [1] TNFSF11 💬 |
Breast cancer [7] Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis |
046 [1] 46 💬 |
643 |
Pralia 60mg subcutaneous injection syringe(denosumab) |
Denosumab |
[1] D03684 D03684 💬 |
TNFSF11 [1] TNFSF11 💬 |
Breast cancer [7] Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis |
046 [1] 46 💬 |
644 |
Praluent |
- |
- |
- |
- |
079 [1] 79 💬 |
645 |
Pramipexol |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
646 |
Pramipexol extended release |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
647 |
Pramipexol immediate release |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
648 |
Pramipexole |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 [2] 2 , 6 💬 |
649 |
Pramipexole 0.125 mg tablets |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
650 |
Pramipexole 0.5 mg tablets |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
651 |
Pramipexole dihydrochloride |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
652 |
Pramipexole dihydrochloride extended-release tablets |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
653 |
Pramipexole dihydrochloride monohydrate |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
654 |
Pramipexole dihydrochloride monohydrate extended release |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
655 |
Pramipexole er |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
656 |
Pramipexole extended release |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
657 |
Pramipexole extended release tablet |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
658 |
Pramipexole hydrochloride sustained-release tablet (siforl®) specification: 0.26mg/ tablet (in pramipexole) |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
659 |
Pramipexole immediate release |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
660 |
Pramipexole immediate release tablet |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
661 |
Pramipexole ir |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
662 |
Pramipexole or ropinirole |
Pramipexole |
[4] D00559 D00559, D00784 D00784, D05575 D05575, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
663 |
Pramipexole sr |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
664 |
Prasterone |
Prasterone |
[1] D08409 D08409 💬 |
AR [3] AR, ESR1, ESR2 💬 |
Breast cancer [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 [1] 49 💬 |
665 |
Prasterone (gl701) |
Prasterone |
[1] D08409 D08409 💬 |
AR [3] AR, ESR1, ESR2 💬 |
Breast cancer [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 [1] 49 💬 |
666 |
Pravastatin |
Pravastatin |
[2] D00893 D00893, D08410 D08410 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [9] 13, 46, 49, 67, 79, 96, 164, 265, 333 💬 |
667 |
Pravastatin sodium |
Pravastatin |
[2] D00893 D00893, D08410 D08410 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
265 [1] 265 💬 |
668 |
Praxol hydrochloride sustained release tablet specification: 0.375mg/ tablet (in pramipexole hydrochloride) |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
669 |
Prd2175434 |
- |
- |
- |
- |
113 [1] 113 💬 |
670 |
Prd4862257 |
- |
- |
- |
- |
046 [1] 46 💬 |
671 |
Prd5973697 |
- |
- |
- |
- |
097 [1] 97 💬 |
672 |
Prd806998 |
- |
- |
- |
- |
013 [1] 13 💬 |
673 |
Pre-filled syringe |
- |
- |
- |
- |
046 [1] 46 💬 |
674 |
Prebiotics |
- |
- |
- |
- |
096 [1] 96 💬 |
675 |
Prebiotics (prebiotin prebiotic fiber stick pac) |
- |
- |
- |
- |
013 [1] 13 💬 |
676 |
Pred |
- |
- |
- |
- |
046 [1] 46 💬 |
677 |
Pred + meth |
- |
- |
- |
- |
046 [1] 46 💬 |
678 |
Predinose oral |
- |
- |
- |
- |
070 [1] 70 💬 |
679 |
Prednihexal |
- |
- |
- |
- |
046 [1] 46 💬 |
680 |
Prednihexal® 10mg tabletten |
- |
- |
- |
- |
046 [1] 46 💬 |
681 |
Prednihexal® 20mg tabletten |
- |
- |
- |
- |
046 [1] 46 💬 |
682 |
Prednihexal® 5mg tabletten |
- |
- |
- |
- |
046 [1] 46 💬 |
683 |
Prednihexal® 5mg tabletten, prednihexal® 10mg tabletten |
- |
- |
- |
- |
046 [1] 46 💬 |
684 |
Prednihexal® 5mg tabletten, prednihexal® 20mg tabletten |
- |
- |
- |
- |
046 [1] 46 💬 |
685 |
Predniso |
- |
- |
- |
- |
046 [1] 46 💬 |
686 |
Prednisolene tablets bp 1 mg |
- |
- |
- |
- |
046 [1] 46 💬 |
687 |
Prednisolon |
- |
- |
- |
- |
046 [6] 46, 50, 51, 66, 96, 97 💬 |
688 |
Prednisolon 1 mg jenapharm |
- |
- |
- |
- |
041 [1] 41 💬 |
689 |
Prednisolon 5 mg jenapharm |
- |
- |
- |
- |
041 [1] 41 💬 |
690 |
Prednisolon jenapharm |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
691 |
Prednisolon pfizer |
- |
- |
- |
- |
050 [1] 50 💬 |
692 |
Prednisolona |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
051 [1] 51 💬 |
693 |
Prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
011 [40] 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
694 |
Prednisolone & dipyridamole |
Dipyridamole |
[9] D00302 D00302, D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [3] NR3C1, PDE4A, PDE5A 💬 |
Metabolic pathways [7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
695 |
Prednisolone + mabthera |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
061 [1] 61 💬 |
696 |
Prednisolone 1mg tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
697 |
Prednisolone 2,5 mg tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
698 |
Prednisolone 20 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
699 |
Prednisolone 40 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
700 |
Prednisolone 5 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [2] 46, 51 💬 |
701 |
Prednisolone 5 mg jenapharm |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
041 [1] 41 💬 |
702 |
Prednisolone 5 mg tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
703 |
Prednisolone 5mg gastro-resistant tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
051 [1] 51 💬 |
704 |
Prednisolone 5mg tablet |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
705 |
Prednisolone acetate |
Acetate |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
222 [1] 222 💬 |
706 |
Prednisolone and chlorambucil |
Chlorambucil |
[9] D00266 D00266, D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
222 [1] 222 💬 |
707 |
Prednisolone and mycophenolate mofetil |
Mycophenolate mofetil |
[12] D00472 D00472, D00752 D00752, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [3] IMPDH1, IMPDH2, NR3C1 💬 |
Drug metabolism - other enzymes [4] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism |
222 [1] 222 💬 |
708 |
Prednisolone and taper |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
051 [1] 51 💬 |
709 |
Prednisolone labesfal |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
710 |
Prednisolone sodium metasulphobenzoate |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
711 |
Prednisolone sodium phosphate |
Phosphate ion |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [2] 13, 97 💬 |
712 |
Prednisolone sodium succinate |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
095 [1] 95 💬 |
713 |
Prednisolone tablets b.p. 5mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
714 |
Prednisolone tablets bp |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
715 |
Prednisolone tablets bp 1 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
716 |
Prednisolone tablets usp 5 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
717 |
Prednisolone-dipyridamole |
Dipyridamole |
[9] D00302 D00302, D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [3] NR3C1, PDE4A, PDE5A 💬 |
Metabolic pathways [7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
718 |
Prednisolone/prednisone |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [1] 49 💬 |
719 |
Prednisoloni |
- |
- |
- |
- |
051 [1] 51 💬 |
720 |
Prednisolonum |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
051 [1] 51 💬 |
721 |
Prednison |
- |
- |
- |
- |
046 [3] 46, 84, 113 💬 |
722 |
Prednison 5, 20 léciva por. tablet nob |
- |
- |
- |
- |
050 [1] 50 💬 |
723 |
Prednison 5, 20 léciva por. tablet nob. |
- |
- |
- |
- |
050 [1] 50 💬 |
724 |
Prednison acis® 20 mg |
- |
- |
- |
- |
043 [2] 43, 44 💬 |
725 |
Prednison acis® 5 mg |
- |
- |
- |
- |
043 [2] 43, 44 💬 |
726 |
Prednisona |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [3] 46, 49, 222 💬 |
727 |
Prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [47] 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
728 |
Prednisone (and methylprednisolone) |
Methylprednisolone |
[7] D00407 D00407, D00473 D00473, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
043 [1] 43 💬 |
729 |
Prednisone + inhibace/cozaar |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
730 |
Prednisone - azathioprine |
Azathioprine |
[3] D00238 D00238, D00473 D00473, D03033 D03033 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
011 [1] 11 💬 |
731 |
Prednisone 0,5 mg/kg orally on alternate days |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
222 [1] 222 💬 |
732 |
Prednisone 1 mg |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
733 |
Prednisone 15 mg |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
734 |
Prednisone 2 mg |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
735 |
Prednisone 3 mg |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
736 |
Prednisone 4 mg |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
737 |
Prednisone 5 mg |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [2] 46, 66 💬 |
738 |
Prednisone 5 mg tablets |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
113 [1] 113 💬 |
739 |
Prednisone 7.5 mg |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
740 |
Prednisone acetate |
Acetate |
[2] D00473 D00473, D08416 D08416 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
040 [3] 40, 49, 224 💬 |
741 |
Prednisone acetate tablets |
Acetate |
[2] D00473 D00473, D08416 D08416 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
224 [1] 224 💬 |
742 |
Prednisone alone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
011 [2] 11, 66 💬 |
743 |
Prednisone and belimumab |
Belimumab |
[2] D00473 D00473, D03068 D03068 💬 |
NR3C1 [2] NR3C1, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Rheumatoid arthritis |
300 [1] 300 💬 |
744 |
Prednisone and cyclophosphamide |
Cyclophosphamide |
[3] D00287 D00287, D00473 D00473, D07760 D07760 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
745 |
Prednisone and mycophenolate mofetil |
Mycophenolate mofetil |
[5] D00473 D00473, D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [3] IMPDH1, IMPDH2, NR3C1 💬 |
Drug metabolism - other enzymes [4] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism |
300 [1] 300 💬 |
746 |
Prednisone and ustekinumab treatment |
Prednisone |
[2] D00473 D00473, D09214 D09214 💬 |
IL12A [4] IL12A, IL12B, IL23A, NR3C1 💬 |
African trypanosomiasis [27] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Neuroactive ligand-receptor interaction, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
041 [1] 41 💬 |
747 |
Prednisone arrow 20mg |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
748 |
Prednisone arrow 5 mg |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
749 |
Prednisone capsules |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
041 [1] 41 💬 |
750 |
Prednisone discontinuation |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [1] 49 💬 |
751 |
Prednisone in full dose |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
752 |
Prednisone or prednisolone |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
753 |
Prednisone plus cyclophosphamide |
Cyclophosphamide |
[3] D00287 D00287, D00473 D00473, D07760 D07760 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
754 |
Prednisone tablets usp, 1 mg |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
041 [2] 41, 46 💬 |
755 |
Prednisone tablets usp, 2.5 mg |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
041 [1] 41 💬 |
756 |
Prednisone tablets usp, 5 mg |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
041 [2] 41, 46 💬 |
757 |
Prednisone tablets, usp |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
041 [3] 41, 43, 44 💬 |
758 |
Prednisone therapy and pharmacokinetic |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
041 [1] 41 💬 |
759 |
Prednisone treatment |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
041 [1] 41 💬 |
760 |
Prednisone, ciclosporin and mycophenolate mofetil |
Cyclosporine |
[6] D00184 D00184, D00473 D00473, D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [8] IMPDH1, IMPDH2, NR3C1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [36] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
222 [1] 222 💬 |
761 |
Prednisone, cyclophosphamide |
Cyclophosphamide |
[3] D00287 D00287, D00473 D00473, D07760 D07760 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
040 [1] 40 💬 |
762 |
Prednisone, fk506, mmf |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
222 [1] 222 💬 |
763 |
Prednisone, low dose rituximab |
Prednisone |
[2] D00473 D00473, D02994 D02994 💬 |
MS4A1 [2] MS4A1, NR3C1 💬 |
Hematopoietic cell lineage [2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction |
061 [1] 61 💬 |
764 |
Prednisone, methylprednisolone,cyclophosphamides |
Methylprednisolone |
[7] D00407 D00407, D00473 D00473, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
042 [3] 42, 43, 45 💬 |
765 |
Prednisone/prednisolone |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [1] 35 💬 |
766 |
Prednizolon |
- |
- |
- |
- |
051 [1] 51 💬 |
767 |
Prednizolonas |
- |
- |
- |
- |
051 [1] 51 💬 |
768 |
Prefilled liquid etanercept(yisaipu) |
Etanercept |
[1] D00742 D00742 💬 |
LTA [2] LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
271 [1] 271 💬 |
769 |
Prefilled syringe delivery of golimumab |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
770 |
Prefolic*30cpr gastror 15mg |
- |
- |
- |
- |
299 [1] 299 💬 |
771 |
Pregabalin |
Pregabalin |
[1] D02716 D02716 💬 |
CACNA2D1 [4] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 |
Adrenergic signaling in cardiomyocytes [7] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
013 [5] 13, 36, 46, 70, 298 💬 |
772 |
Pregabalin 75mg |
Pregabalin |
[1] D02716 D02716 💬 |
CACNA2D1 [4] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 |
Adrenergic signaling in cardiomyocytes [7] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
070 [1] 70 💬 |
773 |
Preimplantation factor |
Preimplantation factor |
- |
- |
- |
095 [1] 95 💬 |
774 |
Preladenant |
Preladenant |
[1] D09717 D09717 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
775 |
Preladenant 10 mg tablet |
Preladenant |
[1] D09717 D09717 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
776 |
Preladenant 2 mg tablet |
Preladenant |
[1] D09717 D09717 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
777 |
Preladenant 5 mg tablet |
Preladenant |
[1] D09717 D09717 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
778 |
Premarin and provera |
- |
- |
- |
- |
049 [1] 49 💬 |
779 |
Premarin ® |
- |
- |
- |
- |
006 [1] 6 💬 |
780 |
Preotact |
- |
- |
- |
- |
235 [1] 235 💬 |
781 |
Preparative regimen 4-6 weeks after leukapheresis |
- |
- |
- |
- |
096 [1] 96 💬 |
782 |
Prepulsid |
- |
- |
- |
- |
013 [1] 13 💬 |
783 |
Preservative free artificial tear gel. |
- |
- |
- |
- |
157 [1] 157 💬 |
784 |
Prevenar |
- |
- |
- |
- |
065 [1] 65 💬 |
785 |
Prevenar 13 |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
786 |
Prevenar vaccination |
- |
- |
- |
- |
046 [1] 46 💬 |
787 |
Prevenar vaccine |
- |
- |
- |
- |
046 [1] 46 💬 |
788 |
Prevenar13 |
- |
- |
- |
- |
019 [2] 19, 265 💬 |
789 |
Prevenar® and pneumo23® |
- |
- |
- |
- |
049 [1] 49 💬 |
790 |
Previously known as r935788 |
- |
- |
- |
- |
046 [1] 46 💬 |
791 |
Previously referred to as medi2070 and amg 139 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
792 |
Previously referred to as medi2070 and amg 139, agn-151-598 |
- |
- |
- |
- |
096 [1] 96 💬 |
793 |
Prgcd |
Taliglucerase alfa |
[1] D09675 D09675 💬 |
GBA [1] GBA 💬 |
Lysosome [4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 [1] 19 💬 |
794 |
Pridia (donepezil hydrochloride) 5mg |
Donepezil |
[2] D00670 D00670, D07869 D07869 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
795 |
Pridia 10mg |
- |
- |
- |
- |
006 [1] 6 💬 |
796 |
Pridia 5mg |
- |
- |
- |
- |
006 [1] 6 💬 |
797 |
Pridiopidine |
- |
- |
- |
- |
008 [1] 8 💬 |
798 |
Pridopidina |
- |
- |
- |
- |
008 [1] 8 💬 |
799 |
Pridopidine |
Pridopidine |
[1] D09953 D09953 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 [3] 2 , 6 , 8 💬 |
800 |
Pridopidine (90 mg) |
Pridopidine |
[1] D09953 D09953 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
008 [1] 8 💬 |
801 |
Pridopidine hydrochloride |
Pridopidine |
[1] D09953 D09953 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
008 [1] 8 💬 |
802 |
Prim-dj2727 |
- |
- |
- |
- |
006 [2] 6 , 97 💬 |
803 |
Primary cervical dystonia (trihexyphenidyl) |
Trihexyphenidyl |
[2] D00787 D00787, D08638 D08638 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [1] 6 💬 |
804 |
Primavanserin tartrate |
- |
- |
- |
- |
006 [1] 6 💬 |
805 |
Primus |
Florasulam |
- |
- |
- |
046 [1] 46 💬 |
806 |
Prior donepezil 5mg |
Donepezil |
[2] D00670 D00670, D07869 D07869 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
807 |
Prior donzepezil 10mg |
- |
- |
- |
- |
006 [1] 6 💬 |
808 |
Privigen |
- |
- |
- |
- |
011 [4] 11, 14, 51, 65 💬 |
809 |
Privigen 100 mg/ml, solution pour perfusion |
- |
- |
- |
- |
053 [1] 53 💬 |
810 |
Privigen 100mg/ml |
- |
- |
- |
- |
085 [1] 85 💬 |
811 |
Privigen® |
- |
- |
- |
- |
014 [3] 14, 63, 65 💬 |
812 |
Privigen® 100mg/ml at the dose of 2g/kg of body weight |
- |
- |
- |
- |
053 [1] 53 💬 |
813 |
Prm-151 |
PRM-151 |
- |
- |
- |
085 [1] 85 💬 |
814 |
Prn1008 |
- |
- |
- |
- |
035 [1] 35 💬 |
815 |
Prn1008 (rilzabrutinib) |
- |
- |
- |
- |
035 [1] 35 💬 |
816 |
Prn1008 freebase |
- |
- |
- |
- |
035 [1] 35 💬 |
817 |
Prn1008 oral tablet |
- |
- |
- |
- |
035 [1] 35 💬 |
818 |
Prn2246 |
- |
- |
- |
- |
013 [1] 13 💬 |
819 |
Pro044 |
- |
- |
- |
- |
113 [1] 113 💬 |
820 |
Pro044 iv |
- |
- |
- |
- |
113 [1] 113 💬 |
821 |
Pro044 iv 6 mg/kg |
- |
- |
- |
- |
113 [1] 113 💬 |
822 |
Pro044 iv 9 mg/kg |
- |
- |
- |
- |
113 [1] 113 💬 |
823 |
Pro044 sc |
- |
- |
- |
- |
113 [1] 113 💬 |
824 |
Pro044 sc 6 mg/kg |
- |
- |
- |
- |
113 [1] 113 💬 |
825 |
Pro045 |
- |
- |
- |
- |
113 [1] 113 💬 |
826 |
Pro045, 0.15 mg/kg/week |
- |
- |
- |
- |
113 [1] 113 💬 |
827 |
Pro045, 1.0 mg/kg/week |
- |
- |
- |
- |
113 [1] 113 💬 |
828 |
Pro045, 3.0 mg/kg/week |
- |
- |
- |
- |
113 [1] 113 💬 |
829 |
Pro045, 6.0 mg/kg/week |
- |
- |
- |
- |
113 [1] 113 💬 |
830 |
Pro045, 9.0 mg/kg/week |
- |
- |
- |
- |
113 [1] 113 💬 |
831 |
Pro045, selected dose |
- |
- |
- |
- |
113 [1] 113 💬 |
832 |
Pro051 |
- |
- |
- |
- |
113 [1] 113 💬 |
833 |
Pro053 |
- |
- |
- |
- |
113 [1] 113 💬 |
834 |
Pro145223 |
- |
- |
- |
- |
097 [1] 97 💬 |
835 |
Pro145223 (ro5490261) |
- |
- |
- |
- |
097 [1] 97 💬 |
836 |
Pro283698 |
- |
- |
- |
- |
046 [1] 46 💬 |
837 |
Probenecid |
Probenecid |
[1] D00475 D00475 💬 |
- |
- |
025 [1] 25 💬 |
838 |
Probiotic |
- |
- |
- |
- |
002 [7] 2 , 6 , 93, 96, 97, 193, 266 💬 |
839 |
Probiotic - vsl#3 |
- |
- |
- |
- |
096 [1] 96 💬 |
840 |
Probiotic capsule |
- |
- |
- |
- |
006 [1] 6 💬 |
841 |
Probiotic capsules containing lactobacillus rhamnosus gr-1 and l. reuteri rc-14 |
- |
- |
- |
- |
046 [1] 46 💬 |
842 |
Probiotic formula capsule |
- |
- |
- |
- |
097 [1] 97 💬 |
843 |
Probiotic mixture |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
844 |
Probiotic product - cap |
- |
- |
- |
- |
053 [1] 53 💬 |
845 |
Probiotic treatment |
- |
- |
- |
- |
294 [1] 294 💬 |
846 |
Probiotic-lactobacillus plantarum ps128 |
Lactobacillus plantarum |
- |
- |
- |
156 [1] 156 💬 |
847 |
Probiotics |
- |
- |
- |
- |
094 [4] 94, 96, 97, 291 💬 |
848 |
Probiotics (visbiome®) |
- |
- |
- |
- |
013 [1] 13 💬 |
849 |
Probiotics with prebiotic |
- |
- |
- |
- |
006 [1] 6 💬 |
850 |
Probucol |
Probucol |
[1] D00476 D00476 💬 |
- |
- |
066 [1] 66 💬 |
851 |
Procedure: 12 lead electrocardiogram |
- |
- |
- |
- |
019 [1] 19 💬 |
852 |
Procedure: 12-lead ecg |
- |
- |
- |
- |
140 [2] 140, 144 💬 |
853 |
Procedure: 2 ml of whole blood sample will be collected on edta tube |
Edetic acid |
[8] D00052 D00052, D00571 D00571, D01802 D01802, D03943 D03943, D03944 D03944, D03945 D03945, D03946 D03946, D03947 D03947 💬 |
- |
- |
051 [1] 51 💬 |
854 |
Procedure: 2-hour holter monitor |
Methamidophos |
- |
- |
- |
019 [1] 19 💬 |
855 |
Procedure: 3d electrocardiographic mapping (ecm) |
- |
- |
- |
- |
058 [1] 58 💬 |
856 |
Procedure: 9% sodium chloride (nacl) iv |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
078 [1] 78 💬 |
857 |
Procedure: [123i]-ibzm imaging |
- |
- |
- |
- |
006 [1] 6 💬 |
858 |
Procedure: [123i]beta-cit and spect imaging |
- |
- |
- |
- |
006 [1] 6 💬 |
859 |
Procedure: [123i]ß-cit and spect imaging |
- |
- |
- |
- |
006 [1] 6 💬 |
860 |
Procedure: acupuncture |
- |
- |
- |
- |
046 [2] 46, 70 💬 |
861 |
Procedure: ad-msc transdifferentiated hscs (ad-hscs) |
- |
- |
- |
- |
060 [1] 60 💬 |
862 |
Procedure: adipose derived mesenchymal stem cells ( ad-mscs) |
- |
- |
- |
- |
060 [1] 60 💬 |
863 |
Procedure: adipose tissue harvest |
- |
- |
- |
- |
051 [1] 51 💬 |
864 |
Procedure: air stacking manuever |
- |
- |
- |
- |
003 [1] 3 💬 |
865 |
Procedure: airway clearance technique |
- |
- |
- |
- |
299 [1] 299 💬 |
866 |
Procedure: alcohol wipes vs. no alcohol wipes |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
013 [1] 13 💬 |
867 |
Procedure: allo bmt |
- |
- |
- |
- |
065 [1] 65 💬 |
868 |
Procedure: allogeneic bone marrow transplantation |
- |
- |
- |
- |
060 [6] 60, 65, 96, 164, 284, 285 💬 |
869 |
Procedure: allogeneic hematopoietic stem cell transplantation |
- |
- |
- |
- |
028 [8] 28, 51, 60, 62, 65, 164, 284, 285 💬 |
870 |
Procedure: allogeneic hsc |
- |
- |
- |
- |
065 [1] 65 💬 |
871 |
Procedure: allogeneic hsct |
- |
- |
- |
- |
065 [1] 65 💬 |
872 |
Procedure: allogeneic stem cell transplant |
- |
- |
- |
- |
060 [1] 60 💬 |
873 |
Procedure: allogeneic stem cell transplantation |
- |
- |
- |
- |
019 [3] 19, 20, 62 💬 |
874 |
Procedure: allogenic stem cell transplantation |
- |
- |
- |
- |
060 [1] 60 💬 |
875 |
Procedure: allograft |
- |
- |
- |
- |
070 [1] 70 💬 |
876 |
Procedure: antiviral therapy |
- |
- |
- |
- |
028 [2] 28, 60 💬 |
877 |
Procedure: apheresis |
- |
- |
- |
- |
060 [1] 60 💬 |
878 |
Procedure: apheresis catheter placement |
- |
- |
- |
- |
096 [1] 96 💬 |
879 |
Procedure: arginine and clonidine stimulation testing |
Arginine |
[3] D00281 D00281, D00604 D00604, D02982 D02982 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
078 [1] 78 💬 |
880 |
Procedure: arginine stimulation test after each limb |
Arginine |
[1] D02982 D02982 💬 |
- |
- |
078 [1] 78 💬 |
881 |
Procedure: arthroscopic synovial tissue biopsy |
- |
- |
- |
- |
046 [1] 46 💬 |
882 |
Procedure: assessment of therapy complications |
- |
- |
- |
- |
060 [1] 60 💬 |
883 |
Procedure: audiological and ear, nose and throat examination |
- |
- |
- |
- |
078 [1] 78 💬 |
884 |
Procedure: autologous bone marrow transplantation |
- |
- |
- |
- |
013 [2] 13, 28 💬 |
885 |
Procedure: autologous cd34+hpc transplantation (hsct) |
- |
- |
- |
- |
049 [1] 49 💬 |
886 |
Procedure: autologous hematopoietic stem cell transplant |
- |
- |
- |
- |
013 [1] 13 💬 |
887 |
Procedure: autologous hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 [6] 11, 13, 14, 28, 49, 51 💬 |
888 |
Procedure: autologous hematopoietic stem cell transplantation (asct) |
- |
- |
- |
- |
028 [1] 28 💬 |
889 |
Procedure: autologous peripheral blood stem cell transplantation |
- |
- |
- |
- |
028 [8] 28, 40, 41, 42, 45, 46, 49, 283 💬 |
890 |
Procedure: autologous stem cell transplant |
- |
- |
- |
- |
028 [2] 28, 96 💬 |
891 |
Procedure: autologous stem cell transplantation |
- |
- |
- |
- |
013 [2] 13, 28 💬 |
892 |
Procedure: autologous-autologous tandem hematopoietic stem cell transplantation |
- |
- |
- |
- |
028 [1] 28 💬 |
893 |
Procedure: b-lines se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
894 |
Procedure: ballon pulmonary angioplasty |
- |
- |
- |
- |
088 [1] 88 💬 |
895 |
Procedure: balloon pulmonary angioplasty (bpa) |
- |
- |
- |
- |
088 [1] 88 💬 |
896 |
Procedure: bee venom pharmacopuncture |
- |
- |
- |
- |
070 [1] 70 💬 |
897 |
Procedure: behavior and neuropsychometric evaluations |
- |
- |
- |
- |
078 [1] 78 💬 |
898 |
Procedure: biliary stent |
- |
- |
- |
- |
300 [1] 300 💬 |
899 |
Procedure: biofluid samplings |
- |
- |
- |
- |
006 [1] 6 💬 |
900 |
Procedure: biopsies |
- |
- |
- |
- |
097 [1] 97 💬 |
901 |
Procedure: biopsy |
- |
- |
- |
- |
051 [3] 51, 78, 193 💬 |
902 |
Procedure: biospecimen collection |
- |
- |
- |
- |
159 [1] 159 💬 |
903 |
Procedure: blood analysis |
- |
- |
- |
- |
006 [1] 6 💬 |
904 |
Procedure: blood collection for pk testing (15 mins before injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
905 |
Procedure: blood collection for pk testing (15 minutes post injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
906 |
Procedure: blood collection for pk testing (18-20 hours post injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
907 |
Procedure: blood collection for pk testing (180 minutes post injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
908 |
Procedure: blood collection for pk testing (60 minutes post injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
909 |
Procedure: blood collection for pk testing (after injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
910 |
Procedure: blood draw |
- |
- |
- |
- |
006 [5] 6 , 19, 65, 231, 299 💬 |
911 |
Procedure: blood draw. |
- |
- |
- |
- |
231 [2] 231, 299 💬 |
912 |
Procedure: blood draws |
- |
- |
- |
- |
078 [1] 78 💬 |
913 |
Procedure: blood sample |
- |
- |
- |
- |
065 [1] 65 💬 |
914 |
Procedure: blood sampling for determination of serum zn |
- |
- |
- |
- |
299 [1] 299 💬 |
915 |
Procedure: blood sampling from infant |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
916 |
Procedure: blood sampling from mother |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
917 |
Procedure: blood sampling from umbilical cord |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
918 |
Procedure: blood sampling, endoscopy |
- |
- |
- |
- |
097 [1] 97 💬 |
919 |
Procedure: blue light photopheresis |
- |
- |
- |
- |
096 [1] 96 💬 |
920 |
Procedure: bone densitometry |
- |
- |
- |
- |
162 [1] 162 💬 |
921 |
Procedure: bone marrow ablation with stem cell support |
- |
- |
- |
- |
028 [2] 28, 60 💬 |
922 |
Procedure: bone marrow aspiration |
- |
- |
- |
- |
060 [2] 60, 285 💬 |
923 |
Procedure: bone marrow infusion |
- |
- |
- |
- |
036 [1] 36 💬 |
924 |
Procedure: bone marrow mononuclear cells |
- |
- |
- |
- |
057 [1] 57 💬 |
925 |
Procedure: bone marrow or umbilical cord blood (ucg) stem cell transplantation |
- |
- |
- |
- |
036 [1] 36 💬 |
926 |
Procedure: bone marrow transplant |
- |
- |
- |
- |
060 [1] 60 💬 |
927 |
Procedure: bone marrow transplantation |
- |
- |
- |
- |
051 [4] 51, 60, 284, 285 💬 |
928 |
Procedure: brain magnetic resonance imaging (mri) |
- |
- |
- |
- |
017 [1] 17 💬 |
929 |
Procedure: brain mri/mrs/fmri |
- |
- |
- |
- |
019 [1] 19 💬 |
930 |
Procedure: brain pet scan |
- |
- |
- |
- |
005 [3] 5 , 7 , 127 💬 |
931 |
Procedure: breast milk sampling |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
932 |
Procedure: bronchoalveolar lavage (bal) |
- |
- |
- |
- |
084 [1] 84 💬 |
933 |
Procedure: bronchoscopy with bal |
- |
- |
- |
- |
299 [1] 299 💬 |
934 |
Procedure: bronchoscopy with bronchoalveolar lavage |
- |
- |
- |
- |
084 [1] 84 💬 |
935 |
Procedure: cardiac monitoring |
- |
- |
- |
- |
006 [1] 6 💬 |
936 |
Procedure: carotid ultrasound |
- |
- |
- |
- |
078 [1] 78 💬 |
937 |
Procedure: cd3-depleted hematopoietic cell transplantation |
- |
- |
- |
- |
060 [1] 60 💬 |
938 |
Procedure: cd34 selected haploidentical pbsct |
- |
- |
- |
- |
285 [1] 285 💬 |
939 |
Procedure: cd34+ peripheral blood stem cell reinfusion |
- |
- |
- |
- |
049 [1] 49 💬 |
940 |
Procedure: cd3±cd19 depleted hematopoietic stem cell transplantation |
- |
- |
- |
- |
060 [1] 60 💬 |
941 |
Procedure: celiac block with triamcinolone and bupivicaine |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
298 [1] 298 💬 |
942 |
Procedure: chuna manipulation |
- |
- |
- |
- |
070 [1] 70 💬 |
943 |
Procedure: chuna manual medicine |
- |
- |
- |
- |
070 [1] 70 💬 |
944 |
Procedure: clobetasol propionate |
Clobetasol |
[2] D01272 D01272, D07715 D07715 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
162 [1] 162 💬 |
945 |
Procedure: colectomy |
- |
- |
- |
- |
097 [1] 97 💬 |
946 |
Procedure: collagenase |
Collagenase clostridium histolyticum |
[1] D09596 D09596 💬 |
- |
- |
162 [1] 162 💬 |
947 |
Procedure: colonoscopy |
- |
- |
- |
- |
097 [1] 97 💬 |
948 |
Procedure: colorectal biopsies |
- |
- |
- |
- |
097 [1] 97 💬 |
949 |
Procedure: computed tomography |
- |
- |
- |
- |
034 [5] 34, 40, 46, 49, 96 💬 |
950 |
Procedure: continuous glucose monitoring system (cgms) |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
951 |
Procedure: continuous mononuclear cell collection (cmnc) |
- |
- |
- |
- |
096 [1] 96 💬 |
952 |
Procedure: contrast sensitivity measurement |
- |
- |
- |
- |
019 [1] 19 💬 |
953 |
Procedure: control group |
- |
- |
- |
- |
034 [1] 34 💬 |
954 |
Procedure: conventional surgery |
- |
- |
- |
- |
034 [1] 34 💬 |
955 |
Procedure: cord blood |
- |
- |
- |
- |
060 [1] 60 💬 |
956 |
Procedure: cord blood infusion |
- |
- |
- |
- |
060 [1] 60 💬 |
957 |
Procedure: coronary flow reserve se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
958 |
Procedure: ct scan |
- |
- |
- |
- |
065 [1] 65 💬 |
959 |
Procedure: cupping |
- |
- |
- |
- |
070 [1] 70 💬 |
960 |
Procedure: cyclophosphamide |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
065 [1] 65 💬 |
961 |
Procedure: datscan and spect imaging |
- |
- |
- |
- |
006 [1] 6 💬 |
962 |
Procedure: dental evaluation |
- |
- |
- |
- |
078 [1] 78 💬 |
963 |
Procedure: determination of growth hormone status |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
964 |
Procedure: determination of objective and subjective pain threshold |
- |
- |
- |
- |
017 [1] 17 💬 |
965 |
Procedure: dexa scan |
- |
- |
- |
- |
019 [3] 19, 46, 96 💬 |
966 |
Procedure: dexa, blood tests, h.g.p.o, osseous age. |
- |
- |
- |
- |
078 [2] 78, 193 💬 |
967 |
Procedure: diastolic function se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
968 |
Procedure: digital substraction angiography (dsa) |
- |
- |
- |
- |
040 [1] 40 💬 |
969 |
Procedure: drug coated balloon (dcb) |
- |
- |
- |
- |
040 [1] 40 💬 |
970 |
Procedure: dual energy x-ray absorptiometry (dexa) |
- |
- |
- |
- |
299 [1] 299 💬 |
971 |
Procedure: dynamic contrast-enhanced magnetic resonance imaging |
- |
- |
- |
- |
013 [1] 13 💬 |
972 |
Procedure: dysmorphology evaluation |
- |
- |
- |
- |
078 [1] 78 💬 |
973 |
Procedure: ebb + tblb + bal |
- |
- |
- |
- |
084 [1] 84 💬 |
974 |
Procedure: ebus guided transbronchial forceps biopsy (ebus-tbfb) |
- |
- |
- |
- |
084 [1] 84 💬 |
975 |
Procedure: ebus guided transbronchial needle aspiration (ebus-tbna) |
- |
- |
- |
- |
084 [1] 84 💬 |
976 |
Procedure: echocardiogram |
- |
- |
- |
- |
019 [1] 19 💬 |
977 |
Procedure: echocardiography (tee) |
- |
- |
- |
- |
058 [1] 58 💬 |
978 |
Procedure: electroacupuncture |
- |
- |
- |
- |
006 [2] 6 , 70 💬 |
979 |
Procedure: electrophysiologic study |
- |
- |
- |
- |
001 [1] 1 💬 |
980 |
Procedure: embryonic dopamine cell implant surgery |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
981 |
Procedure: endobronchial forceps biopsy |
- |
- |
- |
- |
084 [1] 84 💬 |
982 |
Procedure: endoscopic balloon dilatation |
- |
- |
- |
- |
096 [1] 96 💬 |
983 |
Procedure: endoscopic drainage of the main pancreatic duct |
- |
- |
- |
- |
298 [1] 298 💬 |
984 |
Procedure: endoscopic repair of myelomeningocele before 26 sa |
- |
- |
- |
- |
118 [1] 118 💬 |
985 |
Procedure: endoscopic trans-sphenoidal adenoma resection |
- |
- |
- |
- |
074 [1] 74 💬 |
986 |
Procedure: endothelial cell biopsy |
- |
- |
- |
- |
078 [1] 78 💬 |
987 |
Procedure: enema |
- |
- |
- |
- |
097 [1] 97 💬 |
988 |
Procedure: epidural local anesthetic injection |
- |
- |
- |
- |
070 [1] 70 💬 |
989 |
Procedure: epidural steroid (dexamethasone) injection |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
070 [1] 70 💬 |
990 |
Procedure: epidural steroid injection |
- |
- |
- |
- |
070 [1] 70 💬 |
991 |
Procedure: epidural steroid with local anesthetic injection |
- |
- |
- |
- |
070 [1] 70 💬 |
992 |
Procedure: esophageal dilation |
- |
- |
- |
- |
098 [1] 98 💬 |
993 |
Procedure: esophagogastroduodenoscopy |
- |
- |
- |
- |
098 [1] 98 💬 |
994 |
Procedure: eua with seton placement if necessary |
- |
- |
- |
- |
096 [1] 96 💬 |
995 |
Procedure: eus |
- |
- |
- |
- |
096 [1] 96 💬 |
996 |
Procedure: eus-fna/ebus-tbna + bal |
- |
- |
- |
- |
084 [1] 84 💬 |
997 |
Procedure: ex vivo immunotherapy |
- |
- |
- |
- |
060 [1] 60 💬 |
998 |
Procedure: exergame |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
999 |
Procedure: exhaled nitric oxide |
Nitric Oxide |
[1] D00074 D00074 💬 |
- |
- |
299 [1] 299 💬 |
1000 |
Procedure: exhaled nitric oxide assessment |
Nitric Oxide |
[1] D00074 D00074 💬 |
- |
- |
046 [1] 46 💬 |
1001 |
Procedure: extracorporeal photopheresis |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
1002 |
Procedure: extracorporeal shock wave lithotripsy |
- |
- |
- |
- |
298 [1] 298 💬 |
1003 |
Procedure: fdg-pet |
- |
- |
- |
- |
299 [1] 299 💬 |
1004 |
Procedure: fecal microbiota transplantation |
- |
- |
- |
- |
097 [1] 97 💬 |
1005 |
Procedure: fecal microbiota transplantation (fmt) of fmp30 donor stool |
- |
- |
- |
- |
013 [1] 13 💬 |
1006 |
Procedure: fetal surgery for mmc repair |
- |
- |
- |
- |
118 [1] 118 💬 |
1007 |
Procedure: fibroscan |
- |
- |
- |
- |
171 [1] 171 💬 |
1008 |
Procedure: fluoroscopic swallow evaluation |
- |
- |
- |
- |
006 [1] 6 💬 |
1009 |
Procedure: fmt |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1010 |
Procedure: fmt+mtx |
- |
- |
- |
- |
046 [1] 46 💬 |
1011 |
Procedure: functional hepatic nitrogen clearance |
Nitrogen |
[1] D00083 D00083 💬 |
- |
- |
171 [1] 171 💬 |
1012 |
Procedure: gastrointestinal evaluation |
- |
- |
- |
- |
078 [1] 78 💬 |
1013 |
Procedure: gastroscopy |
- |
- |
- |
- |
097 [1] 97 💬 |
1014 |
Procedure: general anesthesia with tourniquet |
- |
- |
- |
- |
046 [1] 46 💬 |
1015 |
Procedure: general anesthesia without tourniquet |
- |
- |
- |
- |
046 [1] 46 💬 |
1016 |
Procedure: ghrh/arginine stimulation testing |
Arginine |
[2] D02982 D02982, D08523 D08523 💬 |
GHRHR [1] GHRHR 💬 |
Growth hormone synthesis, secretion and action [2] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
078 [1] 78 💬 |
1017 |
Procedure: glucagon stimulation test and insulin tolerance test |
Glucagon |
[2] D00116 D00116, D02118 D02118 💬 |
GCGR [1] GCGR 💬 |
Glucagon signaling pathway [2] Glucagon signaling pathway, Neuroactive ligand-receptor interaction |
078 [1] 78 💬 |
1018 |
Procedure: growth factors laboratory testing |
- |
- |
- |
- |
078 [1] 78 💬 |
1019 |
Procedure: growth hormone stimulation test |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
299 [1] 299 💬 |
1020 |
Procedure: haplo hsct |
- |
- |
- |
- |
060 [1] 60 💬 |
1021 |
Procedure: hematopoietic bone marrow transplantation |
- |
- |
- |
- |
036 [1] 36 💬 |
1022 |
Procedure: hematopoietic stem cell therapy |
- |
- |
- |
- |
013 [1] 13 💬 |
1023 |
Procedure: hematopoietic stem cell transplant |
- |
- |
- |
- |
285 [1] 285 💬 |
1024 |
Procedure: hematopoietic stem cell transplantation |
- |
- |
- |
- |
013 [3] 13, 65, 285 💬 |
1025 |
Procedure: hematopoietic stem cell transplantation (hsct) |
- |
- |
- |
- |
013 [1] 13 💬 |
1026 |
Procedure: hepatocyte transplant |
- |
- |
- |
- |
240 [1] 240 💬 |
1027 |
Procedure: hgpiv diagnosis test |
- |
- |
- |
- |
299 [1] 299 💬 |
1028 |
Procedure: high frequency ultrasonography |
- |
- |
- |
- |
046 [1] 46 💬 |
1029 |
Procedure: history and physical |
- |
- |
- |
- |
231 [1] 231 💬 |
1030 |
Procedure: history and physical exam. |
- |
- |
- |
- |
231 [2] 231, 299 💬 |
1031 |
Procedure: homar-ir diagnosis test |
- |
- |
- |
- |
299 [1] 299 💬 |
1032 |
Procedure: home based balance training |
Isoxaflutole |
- |
- |
- |
006 [2] 6 , 13 💬 |
1033 |
Procedure: hydrocortisone withdrawal |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
1034 |
Procedure: hyperbaric oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
097 [1] 97 💬 |
1035 |
Procedure: hyperbaric oxygen therapy |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
090 [1] 90 💬 |
1036 |
Procedure: hypercortisolism |
- |
- |
- |
- |
075 [1] 75 💬 |
1037 |
Procedure: ileocecal resection |
- |
- |
- |
- |
096 [1] 96 💬 |
1038 |
Procedure: ileocolonoscopy |
- |
- |
- |
- |
096 [1] 96 💬 |
1039 |
Procedure: immunoadsorption |
- |
- |
- |
- |
013 [1] 13 💬 |
1040 |
Procedure: immunosuppressive therapy (ist) |
- |
- |
- |
- |
060 [1] 60 💬 |
1041 |
Procedure: impedance analysis |
- |
- |
- |
- |
162 [1] 162 💬 |
1042 |
Procedure: implant procedure |
- |
- |
- |
- |
046 [1] 46 💬 |
1043 |
Procedure: in vitro-treated bone marrow transplantation |
- |
- |
- |
- |
060 [1] 60 💬 |
1044 |
Procedure: in vitro-treated peripheral blood stem cell transplantation |
- |
- |
- |
- |
060 [2] 60, 65 💬 |
1045 |
Procedure: increased exercise intensity |
- |
- |
- |
- |
113 [1] 113 💬 |
1046 |
Procedure: indirect calorimetry |
- |
- |
- |
- |
299 [1] 299 💬 |
1047 |
Procedure: infection prophylaxis and management |
- |
- |
- |
- |
028 [2] 28, 60 💬 |
1048 |
Procedure: infusion of saline |
- |
- |
- |
- |
097 [1] 97 💬 |
1049 |
Procedure: injection of salivary glands |
- |
- |
- |
- |
002 [1] 2 💬 |
1050 |
Procedure: injections on posterior bladder wall excluding the trigone |
- |
- |
- |
- |
226 [1] 226 💬 |
1051 |
Procedure: injections upper aspect of trigone of urinary bladder |
- |
- |
- |
- |
226 [1] 226 💬 |
1052 |
Procedure: instillation of fibrin glue |
- |
- |
- |
- |
096 [1] 96 💬 |
1053 |
Procedure: intestinal surgery for crohn's disease |
- |
- |
- |
- |
096 [1] 96 💬 |
1054 |
Procedure: intra-articular injection of etanercept |
Etanercept |
[1] D00742 D00742 💬 |
LTA [2] LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
1055 |
Procedure: intra-articular injection of steroid |
- |
- |
- |
- |
046 [1] 46 💬 |
1056 |
Procedure: intraluminal impedance |
- |
- |
- |
- |
098 [1] 98 💬 |
1057 |
Procedure: intravenous catheter |
- |
- |
- |
- |
231 [1] 231 💬 |
1058 |
Procedure: irradiation |
- |
- |
- |
- |
013 [1] 13 💬 |
1059 |
Procedure: iv administration of genetically engineered hematopoietic stem/progenitors cells (hspcs) |
- |
- |
- |
- |
285 [1] 285 💬 |
1060 |
Procedure: iv deployment of csvf in sterile normal saline iv solution |
- |
- |
- |
- |
085 [2] 85, 229 💬 |
1061 |
Procedure: iv glucose tolerance test |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
1062 |
Procedure: land exercises |
- |
- |
- |
- |
046 [1] 46 💬 |
1063 |
Procedure: large bore (19g) histologic needle biopsy of the mediastinal lymph nodes |
- |
- |
- |
- |
084 [1] 84 💬 |
1064 |
Procedure: lateral transperitoneal la |
- |
- |
- |
- |
075 [1] 75 💬 |
1065 |
Procedure: left ventricular contractile reserve se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
1066 |
Procedure: left ventricular outflow tract gradient se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
1067 |
Procedure: leukapheresis |
- |
- |
- |
- |
049 [5] 49, 51, 96, 284, 285 💬 |
1068 |
Procedure: leukopheresis |
- |
- |
- |
- |
051 [1] 51 💬 |
1069 |
Procedure: liver biopsy |
- |
- |
- |
- |
171 [3] 171, 231, 240 💬 |
1070 |
Procedure: liver transplantation |
- |
- |
- |
- |
094 [1] 94 💬 |
1071 |
Procedure: long term oxygen therapy |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
088 [1] 88 💬 |
1072 |
Procedure: lumbar epidural injection |
- |
- |
- |
- |
070 [1] 70 💬 |
1073 |
Procedure: lumbar interlaminar epidural steroid injection |
- |
- |
- |
- |
070 [1] 70 💬 |
1074 |
Procedure: lumbar puncture |
- |
- |
- |
- |
006 [5] 6 , 13, 19, 96, 97 💬 |
1075 |
Procedure: magnetic resonance imaging |
- |
- |
- |
- |
019 [1] 19 💬 |
1076 |
Procedure: magnetic resonance imaging of the brain |
- |
- |
- |
- |
078 [1] 78 💬 |
1077 |
Procedure: management of therapy complications |
- |
- |
- |
- |
028 [2] 28, 60 💬 |
1078 |
Procedure: manual therapy |
- |
- |
- |
- |
070 [1] 70 💬 |
1079 |
Procedure: marrow graft transplantation |
- |
- |
- |
- |
326 [1] 326 💬 |
1080 |
Procedure: matched unrelated donor hematopoietic stem cell transplant |
- |
- |
- |
- |
060 [1] 60 💬 |
1081 |
Procedure: measurement of growth, thyroid and sex hormone levels |
- |
- |
- |
- |
078 [1] 78 💬 |
1082 |
Procedure: measurement of serum infliximab and anti-infliximab antibodies |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
1083 |
Procedure: meg |
- |
- |
- |
- |
006 [1] 6 💬 |
1084 |
Procedure: mesenchymal stem cell transplantation |
- |
- |
- |
- |
036 [2] 36, 274 💬 |
1085 |
Procedure: microcannula harvest adipose derived tissue stromal vascular fraction (tsvf) |
- |
- |
- |
- |
085 [2] 85, 229 💬 |
1086 |
Procedure: mild procedure |
- |
- |
- |
- |
070 [1] 70 💬 |
1087 |
Procedure: minor salivary gland (labial) biopsy |
- |
- |
- |
- |
053 [1] 53 💬 |
1088 |
Procedure: mitral regurgitation se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
1089 |
Procedure: motion analysis |
- |
- |
- |
- |
006 [1] 6 💬 |
1090 |
Procedure: mri |
- |
- |
- |
- |
013 [2] 13, 78 💬 |
1091 |
Procedure: mri imaging with intravenous contrast with gadoterate meglumine |
Gadoteric acid |
[2] D01796 D01796, D08007 D08007 💬 |
- |
- |
053 [1] 53 💬 |
1092 |
Procedure: mri, fdg-pet/ct scans |
- |
- |
- |
- |
034 [1] 34 💬 |
1093 |
Procedure: mri, venipuncture |
- |
- |
- |
- |
049 [1] 49 💬 |
1094 |
Procedure: narrow band imaging |
- |
- |
- |
- |
097 [1] 97 💬 |
1095 |
Procedure: neurology examination |
- |
- |
- |
- |
078 [1] 78 💬 |
1096 |
Procedure: neuropsychological testing |
- |
- |
- |
- |
078 [1] 78 💬 |
1097 |
Procedure: no celiac block |
- |
- |
- |
- |
298 [1] 298 💬 |
1098 |
Procedure: no gas |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
1099 |
Procedure: non-myeloablative high dose immunosuppressive therapy conditioning (hdit) |
- |
- |
- |
- |
049 [1] 49 💬 |
1100 |
Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation |
- |
- |
- |
- |
028 [6] 28, 51, 60, 62, 65, 285 💬 |
1101 |
Procedure: ophthalmologic evaluation |
- |
- |
- |
- |
078 [1] 78 💬 |
1102 |
Procedure: ophthalmology exam |
- |
- |
- |
- |
019 [1] 19 💬 |
1103 |
Procedure: oral glucose tolerance test |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
1104 |
Procedure: order of two elements of surgical procedure |
- |
- |
- |
- |
051 [1] 51 💬 |
1105 |
Procedure: orthopedic evaluation |
- |
- |
- |
- |
078 [1] 78 💬 |
1106 |
Procedure: other intervention(s) |
- |
- |
- |
- |
070 [1] 70 💬 |
1107 |
Procedure: oxygen flow at the optic nerve head measurement |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
019 [1] 19 💬 |
1108 |
Procedure: padn |
- |
- |
- |
- |
086 [1] 86 💬 |
1109 |
Procedure: pelvic floor physical therapy |
- |
- |
- |
- |
226 [1] 226 💬 |
1110 |
Procedure: percutaneous endoscopic gastrostomy with jejunal extension (peg-j) |
- |
- |
- |
- |
006 [1] 6 💬 |
1111 |
Procedure: percutaneous lumbar decompression |
- |
- |
- |
- |
070 [1] 70 💬 |
1112 |
Procedure: peripheral blood stem cell transplantation |
- |
- |
- |
- |
011 [11] 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285 💬 |
1113 |
Procedure: peripheral blood stem cell transplantation (pbsct) |
- |
- |
- |
- |
060 [1] 60 💬 |
1114 |
Procedure: pet/ct |
- |
- |
- |
- |
006 [1] 6 💬 |
1115 |
Procedure: pft |
- |
- |
- |
- |
089 [1] 89 💬 |
1116 |
Procedure: pharmacopuncture |
- |
- |
- |
- |
070 [1] 70 💬 |
1117 |
Procedure: phlebotomy |
- |
- |
- |
- |
254 [1] 254 💬 |
1118 |
Procedure: physical exam and updrs part iii assessment |
- |
- |
- |
- |
006 [1] 6 💬 |
1119 |
Procedure: physiotherapy, exercise, percutaneous gastrostomy feeds |
- |
- |
- |
- |
299 [1] 299 💬 |
1120 |
Procedure: pilocarpine |
Pilocarpine |
[3] D00525 D00525, D02200 D02200, D05478 D05478 💬 |
CHRM2 [2] CHRM2, CHRM3 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
053 [1] 53 💬 |
1121 |
Procedure: planar image with both hands in field of view |
- |
- |
- |
- |
046 [1] 46 💬 |
1122 |
Procedure: plasma exchange |
- |
- |
- |
- |
013 [5] 13, 43, 44, 64, 222 💬 |
1123 |
Procedure: plasma exchange (pe) |
- |
- |
- |
- |
066 [2] 66, 220 💬 |
1124 |
Procedure: plasmapheresis |
- |
- |
- |
- |
011 [3] 11, 49, 222 💬 |
1125 |
Procedure: plex |
- |
- |
- |
- |
011 [1] 11 💬 |
1126 |
Procedure: plf with autograft |
- |
- |
- |
- |
070 [1] 70 💬 |
1127 |
Procedure: positron emission tomography |
- |
- |
- |
- |
040 [4] 40, 46, 49, 96 💬 |
1128 |
Procedure: posterior ra |
- |
- |
- |
- |
075 [1] 75 💬 |
1129 |
Procedure: posterolateral spinal fusion with instrumentation |
- |
- |
- |
- |
070 [1] 70 💬 |
1130 |
Procedure: power doppler ultrasonography |
- |
- |
- |
- |
046 [1] 46 💬 |
1131 |
Procedure: pre liver transplantation laparoscopic hand assisted staging |
- |
- |
- |
- |
094 [1] 94 💬 |
1132 |
Procedure: psychiatric evaluation |
- |
- |
- |
- |
078 [1] 78 💬 |
1133 |
Procedure: pulmonary endarterectomy |
- |
- |
- |
- |
088 [1] 88 💬 |
1134 |
Procedure: pulmonary endarteriectomy |
- |
- |
- |
- |
088 [1] 88 💬 |
1135 |
Procedure: pulmonary function testing |
- |
- |
- |
- |
002 [3] 2 , 228, 299 💬 |
1136 |
Procedure: pulmonary function testing. |
- |
- |
- |
- |
231 [2] 231, 299 💬 |
1137 |
Procedure: pulmonary hemodynamics se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
1138 |
Procedure: quality-of-life assessment |
- |
- |
- |
- |
028 [3] 28, 34, 51 💬 |
1139 |
Procedure: quantiferon-tb gold assay |
Gold |
- |
- |
- |
046 [1] 46 💬 |
1140 |
Procedure: quantitative chemical shift imaging (qcsi) |
- |
- |
- |
- |
019 [1] 19 💬 |
1141 |
Procedure: radiation therapy |
- |
- |
- |
- |
013 [3] 13, 284, 285 💬 |
1142 |
Procedure: radiographs of the thoracic and lumbar spine |
- |
- |
- |
- |
162 [1] 162 💬 |
1143 |
Procedure: rectal dialysis |
- |
- |
- |
- |
097 [1] 97 💬 |
1144 |
Procedure: rectosigmoidoscopy |
- |
- |
- |
- |
097 [1] 97 💬 |
1145 |
Procedure: reduced intensity allogeneic hematopoietic stem cell transplantation |
- |
- |
- |
- |
051 [1] 51 💬 |
1146 |
Procedure: reduced intensity allogeneic transplant |
- |
- |
- |
- |
049 [2] 49, 51 💬 |
1147 |
Procedure: renal sympathetic denervation |
- |
- |
- |
- |
067 [1] 67 💬 |
1148 |
Procedure: repair of cdh w/alloderm |
- |
- |
- |
- |
294 [1] 294 💬 |
1149 |
Procedure: repair of cdh w/sis gold |
Gold |
- |
- |
- |
294 [1] 294 💬 |
1150 |
Procedure: rf catheter ablation |
- |
- |
- |
- |
058 [1] 58 💬 |
1151 |
Procedure: routine drainage surgery |
- |
- |
- |
- |
096 [1] 96 💬 |
1152 |
Procedure: saline injection |
- |
- |
- |
- |
113 [1] 113 💬 |
1153 |
Procedure: sedation with iv propofol |
Propofol |
[1] D00549 D00549 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [1] 6 💬 |
1154 |
Procedure: self bone marrow transplant |
- |
- |
- |
- |
051 [1] 51 💬 |
1155 |
Procedure: sham |
- |
- |
- |
- |
090 [2] 90, 303 💬 |
1156 |
Procedure: sham cystoscopy procedure |
- |
- |
- |
- |
226 [1] 226 💬 |
1157 |
Procedure: sham hyperbaric air |
- |
- |
- |
- |
097 [1] 97 💬 |
1158 |
Procedure: sham padn |
- |
- |
- |
- |
086 [1] 86 💬 |
1159 |
Procedure: sham procedure |
- |
- |
- |
- |
003 [1] 3 💬 |
1160 |
Procedure: sham surgery |
- |
- |
- |
- |
006 [1] 6 💬 |
1161 |
Procedure: sialoendoscopy |
- |
- |
- |
- |
053 [1] 53 💬 |
1162 |
Procedure: sigmoidoscopy |
- |
- |
- |
- |
097 [1] 97 💬 |
1163 |
Procedure: single photon emission computed tomography |
- |
- |
- |
- |
034 [1] 34 💬 |
1164 |
Procedure: skeletal survey |
- |
- |
- |
- |
019 [1] 19 💬 |
1165 |
Procedure: skin biopsy |
- |
- |
- |
- |
019 [2] 19, 84 💬 |
1166 |
Procedure: skin biopsy for the primary fibroblast culture and a 15 ml blood sample (3 unnamed samples of 5ml) in each of the 4 srt patients included. |
- |
- |
- |
- |
102 [1] 102 💬 |
1167 |
Procedure: slit lamp assessment and intra-ocular pressure measurement |
- |
- |
- |
- |
019 [1] 19 💬 |
1168 |
Procedure: small bowel follow trough |
- |
- |
- |
- |
096 [1] 96 💬 |
1169 |
Procedure: sodium bicarbonate |
Sodium bicarbonate |
[1] D01203 D01203 💬 |
- |
- |
299 [1] 299 💬 |
1170 |
Procedure: spect imaging (180 minutes post-injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
1171 |
Procedure: spect imaging (60 minutes post-injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
1172 |
Procedure: speech and modified barium swallow study |
Barium |
- |
- |
- |
019 [1] 19 💬 |
1173 |
Procedure: speech pathology evaluation |
- |
- |
- |
- |
078 [1] 78 💬 |
1174 |
Procedure: spinal anesthesia with tourniquet |
- |
- |
- |
- |
046 [1] 46 💬 |
1175 |
Procedure: spinal anesthesia without tourniquet |
- |
- |
- |
- |
046 [1] 46 💬 |
1176 |
Procedure: spirometry |
- |
- |
- |
- |
299 [1] 299 💬 |
1177 |
Procedure: spleen sample |
- |
- |
- |
- |
061 [1] 61 💬 |
1178 |
Procedure: sputum collection |
- |
- |
- |
- |
299 [1] 299 💬 |
1179 |
Procedure: stage ii surgical repair |
- |
- |
- |
- |
211 [1] 211 💬 |
1180 |
Procedure: standardized fmt |
- |
- |
- |
- |
097 [1] 97 💬 |
1181 |
Procedure: static, dynamic and functional balance exercises |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
1182 |
Procedure: static, dynamic and functional balance exercises with dual task |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
1183 |
Procedure: status post lung transplant |
- |
- |
- |
- |
228 [1] 228 💬 |
1184 |
Procedure: stem cell collection |
- |
- |
- |
- |
028 [1] 28 💬 |
1185 |
Procedure: stem cell infusion |
- |
- |
- |
- |
028 [5] 28, 60, 65, 284, 285 💬 |
1186 |
Procedure: stem cell or umbilical cord blood transplantation |
- |
- |
- |
- |
326 [1] 326 💬 |
1187 |
Procedure: stem cell transplant |
- |
- |
- |
- |
019 [5] 19, 20, 65, 164, 284 💬 |
1188 |
Procedure: stem cell transplantation |
- |
- |
- |
- |
019 [6] 19, 51, 60, 62, 65, 326 💬 |
1189 |
Procedure: stool samples |
- |
- |
- |
- |
097 [1] 97 💬 |
1190 |
Procedure: supplemental oxygen via a mask |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
088 [1] 88 💬 |
1191 |
Procedure: surgery to implant human cns stem cells (hucns-sc) |
- |
- |
- |
- |
019 [1] 19 💬 |
1192 |
Procedure: surgery treatment |
- |
- |
- |
- |
291 [1] 291 💬 |
1193 |
Procedure: syngeneic bone marrow transplantation |
- |
- |
- |
- |
011 [3] 11, 13, 14 💬 |
1194 |
Procedure: synovial biopsy |
- |
- |
- |
- |
046 [1] 46 💬 |
1195 |
Procedure: taking of blood |
- |
- |
- |
- |
113 [1] 113 💬 |
1196 |
Procedure: testosterone injection |
Testosterone |
[6] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
265 [1] 265 💬 |
1197 |
Procedure: thymectomy plus prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
011 [1] 11 💬 |
1198 |
Procedure: thymic shielding during radiation |
- |
- |
- |
- |
285 [1] 285 💬 |
1199 |
Procedure: tissue biopsy |
- |
- |
- |
- |
001 [1] 1 💬 |
1200 |
Procedure: tissue samplings |
- |
- |
- |
- |
006 [1] 6 💬 |
1201 |
Procedure: tof repair with trans-annular patch vs preservation of pv |
- |
- |
- |
- |
215 [1] 215 💬 |
1202 |
Procedure: total body irradiation |
- |
- |
- |
- |
019 [6] 19, 20, 51, 60, 65, 285 💬 |
1203 |
Procedure: total lymphoid irradiation |
- |
- |
- |
- |
065 [3] 65, 284, 326 💬 |
1204 |
Procedure: total thyroidectomy |
- |
- |
- |
- |
235 [1] 235 💬 |
1205 |
Procedure: total-body irradiation |
- |
- |
- |
- |
051 [1] 51 💬 |
1206 |
Procedure: trans-right ventricular alcohol septal ablation (trvasa) |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
058 [1] 58 💬 |
1207 |
Procedure: transfusion |
- |
- |
- |
- |
096 [1] 96 💬 |
1208 |
Procedure: transsphenoidal surgery treatment |
- |
- |
- |
- |
074 [1] 74 💬 |
1209 |
Procedure: treatment according to current standards without knowledge of serum infliximab and anti-infliximab ab status |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
1210 |
Procedure: tuberculin skin test |
- |
- |
- |
- |
046 [1] 46 💬 |
1211 |
Procedure: ultrasound |
- |
- |
- |
- |
171 [1] 171 💬 |
1212 |
Procedure: umbilical cord blood therapy |
Umbilical Cord Blood Hematopoietic Stem Cells |
- |
- |
- |
002 [2] 2 , 6 💬 |
1213 |
Procedure: umbilical cord blood transplantation |
- |
- |
- |
- |
060 [5] 60, 65, 284, 285, 326 💬 |
1214 |
Procedure: upper limb muscle block |
- |
- |
- |
- |
149 [1] 149 💬 |
1215 |
Procedure: urinary collect |
- |
- |
- |
- |
299 [1] 299 💬 |
1216 |
Procedure: urine collection |
- |
- |
- |
- |
019 [1] 19 💬 |
1217 |
Procedure: urodynamic study |
- |
- |
- |
- |
226 [1] 226 💬 |
1218 |
Procedure: use of an electronic data capture system by patients and physicians to assess patient-physician interactions & therapeutic decisions & outcomes in ra subjects. |
Bifenthrin |
- |
- |
- |
046 [1] 46 💬 |
1219 |
Procedure: venipunctures |
- |
- |
- |
- |
084 [1] 84 💬 |
1220 |
Procedure: videofluoroscopic swallowing study |
- |
- |
- |
- |
002 [1] 2 💬 |
1221 |
Procedure: videofluoroscopic swallowing study (vfss) |
- |
- |
- |
- |
002 [1] 2 💬 |
1222 |
Procedure: visual field testing |
- |
- |
- |
- |
019 [1] 19 💬 |
1223 |
Procedure: warm compress prior to injection of glatiramer acetate |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
1224 |
Procedure: water exercises |
Water |
[1] D00001 D00001 💬 |
- |
- |
046 [1] 46 💬 |
1225 |
Procedure: whole body planar spect imaging (15 minutes post-injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
1226 |
Procedure: whole body planar spect imaging (18-20 hours post-injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
1227 |
Procedure: whole body planar spect imaging (180 minutes post-injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
1228 |
Procedure: whole body planar spect imaging (60 minutes post-injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
1229 |
Procedure: whole body protein turnover |
- |
- |
- |
- |
019 [4] 19, 46, 96, 299 💬 |
1230 |
Procedure: whole body protein turnover study |
- |
- |
- |
- |
299 [1] 299 💬 |
1231 |
Procedure: whole lung lavage(wll) |
- |
- |
- |
- |
229 [1] 229 💬 |
1232 |
Procedure: wll |
- |
- |
- |
- |
229 [1] 229 💬 |
1233 |
Procedure: wmt |
- |
- |
- |
- |
096 [1] 96 💬 |
1234 |
Prochymal (remestemcel-l) |
Remestemcel-L |
[1] D09719 D09719 💬 |
- |
- |
096 [1] 96 💬 |
1235 |
Prochymal adult human mesenchymal stem cells |
Remestemcel-L |
[1] D09719 D09719 💬 |
- |
- |
096 [1] 96 💬 |
1236 |
Prochymal™ adult human mesenchymal stem cells |
Remestemcel-L |
[1] D09719 D09719 💬 |
- |
- |
096 [1] 96 💬 |
1237 |
Procysbi |
- |
- |
- |
- |
019 [1] 19 💬 |
1238 |
Prodarsan |
- |
- |
- |
- |
192 [1] 192 💬 |
1239 |
Products containing aminosalicylate |
- |
- |
- |
- |
097 [1] 97 💬 |
1240 |
Products containing azathioprine or 6-mercaptopurine |
Azathioprine |
[4] D00161 D00161, D00238 D00238, D03033 D03033, D04931 D04931 💬 |
HPRT1 [1] HPRT1 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
097 [1] 97 💬 |
1241 |
Progerinin |
- |
- |
- |
- |
191 [2] 191, 333 💬 |
1242 |
Prograf |
- |
- |
- |
- |
060 [3] 60, 222, 226 💬 |
1243 |
Prograft capsules |
- |
- |
- |
- |
299 [1] 299 💬 |
1244 |
Progressive spacing of tnf-blocker injections |
- |
- |
- |
- |
046 [1] 46 💬 |
1245 |
Prohance (gadoteridol) |
Gadoteridol |
[1] D01137 D01137 💬 |
- |
- |
013 [1] 13 💬 |
1246 |
Prolastin |
- |
- |
- |
- |
231 [3] 231, 298, 299 💬 |
1247 |
Prolastin (drug) |
- |
- |
- |
- |
299 [1] 299 💬 |
1248 |
Prolastin-c |
- |
- |
- |
- |
231 [2] 231, 298 💬 |
1249 |
Prolastin-c, 120 mg/kg |
- |
- |
- |
- |
231 [1] 231 💬 |
1250 |
Prolastin-c, 60 mg/kg |
- |
- |
- |
- |
231 [1] 231 💬 |
1251 |
Proleukin |
- |
- |
- |
- |
002 [3] 2 , 49, 65 💬 |
1252 |
Proleukin 18 mui |
- |
- |
- |
- |
002 [1] 2 💬 |
1253 |
Proleukin® s |
- |
- |
- |
- |
065 [1] 65 💬 |
1254 |
Prolia |
- |
- |
- |
- |
274 [1] 274 💬 |
1255 |
Proline |
Proline |
[1] D00035 D00035 💬 |
- |
- |
094 [2] 94, 97 💬 |
1256 |
Prolonged release tablet |
- |
- |
- |
- |
006 [1] 6 💬 |
1257 |
Prolonged-release fampridine |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
1258 |
Prolopa® |
- |
- |
- |
- |
006 [1] 6 💬 |
1259 |
Prolotherapy solution of 20% dextrose |
Dextrose, unspecified form |
- |
- |
- |
070 [1] 70 💬 |
1260 |
Promacta |
- |
- |
- |
- |
063 [2] 63, 65 💬 |
1261 |
Promethazine |
Promethazine |
[4] D00480 D00480, D00494 D00494, D01242 D01242, D03290 D03290 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
1262 |
Promethera hepastem |
- |
- |
- |
- |
251 [1] 251 💬 |
1263 |
Prometic's immune globulin intravenous 10% |
- |
- |
- |
- |
065 [1] 65 💬 |
1264 |
Promiten |
- |
- |
- |
- |
097 [1] 97 💬 |
1265 |
Promixin |
- |
- |
- |
- |
299 [1] 299 💬 |
1266 |
Promixin 1 million international units (iu) powder for nebuliser solution |
- |
- |
- |
- |
299 [1] 299 💬 |
1267 |
Promixin*nebul 30monod 1mui |
- |
- |
- |
- |
299 [1] 299 💬 |
1268 |
Promixin, 1 million international units (iu) powder for nebuliser solution |
- |
- |
- |
- |
299 [1] 299 💬 |
1269 |
Promixin,1 millón de unidades internacionales,polvo para solución para inhalación por nebulizador |
- |
- |
- |
- |
299 [1] 299 💬 |
1270 |
Promixin/tadim |
- |
- |
- |
- |
299 [1] 299 💬 |
1271 |
Propagermanium |
- |
- |
- |
- |
222 [1] 222 💬 |
1272 |
Propanoic acid |
Propanoic acid |
[1] D02310 D02310 💬 |
- |
- |
006 [2] 6 , 271 💬 |
1273 |
Propanolol |
Propranolol |
[2] D00483 D00483, D08443 D08443 💬 |
ADRB1 [3] ADRB1, ADRB2, ADRB3 💬 |
Adrenergic signaling in cardiomyocytes [11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway |
296 [1] 296 💬 |
1274 |
Propantheline |
Propantheline |
[1] D00481 D00481 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
026 [1] 26 💬 |
1275 |
Propantheline bromide |
Propantheline |
[1] D00481 D00481 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
026 [1] 26 💬 |
1276 |
Prophylactic vaccine (tetanus, diphtheria, pertussis, poliomyelitis, influenza, hepatitis a, hepatitis b, tick-borne encephalitis, meningococcal, pneumococcal) |
- |
- |
- |
- |
013 [1] 13 💬 |
1277 |
Propionyl l-carnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
097 [1] 97 💬 |
1278 |
Propionyl l-carnitine hydrochloride |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
097 [1] 97 💬 |
1279 |
Propionyl-l-carnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
097 [1] 97 💬 |
1280 |
Propionylcarnitinhydrochlorid |
- |
- |
- |
- |
097 [1] 97 💬 |
1281 |
Propiverine |
Propiverine |
[1] D08441 D08441 💬 |
CACNA1C [9] CACNA1C, CACNA1D, CACNA1F, CACNA1S, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Adrenergic signaling in cardiomyocytes [42] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of actin cytoskeleton, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
226 [1] 226 💬 |
1282 |
Propiverine hydrochloride |
Propiverine |
[1] D08441 D08441 💬 |
CACNA1C [9] CACNA1C, CACNA1D, CACNA1F, CACNA1S, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Adrenergic signaling in cardiomyocytes [42] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of actin cytoskeleton, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
226 [1] 226 💬 |
1283 |
Propofol |
Propofol |
[1] D00549 D00549 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [8] 6 , 21, 22, 34, 46, 84, 98, 296 💬 |
1284 |
Propofol-lipuro |
Propofol |
[1] D00549 D00549 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [1] 6 💬 |
1285 |
Propolipid |
- |
- |
- |
- |
046 [1] 46 💬 |
1286 |
Proposed inn - filgotinib |
Filgotinib |
[1] D10871 D10871 💬 |
JAK1 [1] JAK1 💬 |
Coronavirus disease - COVID-19 [27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [1] 46 💬 |
1287 |
Propranolol |
Propranolol |
[2] D00483 D00483, D08443 D08443 💬 |
ADRB1 [3] ADRB1, ADRB2, ADRB3 💬 |
Adrenergic signaling in cardiomyocytes [11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [5] 6 , 158, 167, 227, 278 💬 |
1288 |
Propranolol hcl cf 40 mg tablet |
Propranolol |
[2] D00483 D00483, D08443 D08443 💬 |
ADRB1 [3] ADRB1, ADRB2, ADRB3 💬 |
Adrenergic signaling in cardiomyocytes [11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
1289 |
Propranolol treatment |
Propranolol |
[2] D00483 D00483, D08443 D08443 💬 |
ADRB1 [3] ADRB1, ADRB2, ADRB3 💬 |
Adrenergic signaling in cardiomyocytes [11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway |
227 [1] 227 💬 |
1290 |
Propsoed inn - filgotinib |
Filgotinib |
[1] D10871 D10871 💬 |
JAK1 [1] JAK1 💬 |
Coronavirus disease - COVID-19 [27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [1] 46 💬 |
1291 |
Propylene glycol |
Propylene glycol |
[1] D00078 D00078 💬 |
- |
- |
028 [2] 28, 51 💬 |
1292 |
Propylene glycol-free melphalan hydrochloride |
Melphalan |
[2] D00078 D00078, D00369 D00369 💬 |
- |
- |
028 [1] 28 💬 |
1293 |
Prosavin |
- |
- |
- |
- |
006 [1] 6 💬 |
1294 |
Proscar*30cpr riv 5mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1295 |
Prostacyclin |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
1296 |
Prostanoids |
- |
- |
- |
- |
051 [1] 51 💬 |
1297 |
Proteasa |
- |
- |
- |
- |
299 [1] 299 💬 |
1298 |
Protease |
- |
- |
- |
- |
299 [1] 299 💬 |
1299 |
Protease inhibitor |
- |
- |
- |
- |
265 [1] 265 💬 |
1300 |
Protease inhibitors |
- |
- |
- |
- |
265 [1] 265 💬 |
1301 |
Protectis |
- |
- |
- |
- |
066 [1] 66 💬 |
1302 |
Protein |
- |
- |
- |
- |
046 [2] 46, 67 💬 |
1303 |
Protein intake |
- |
- |
- |
- |
240 [1] 240 💬 |
1304 |
Protein-carbohydrate supplementation |
- |
- |
- |
- |
113 [1] 113 💬 |
1305 |
Proteína recombinante estimulante de la megacariopoyesis |
- |
- |
- |
- |
063 [1] 63 💬 |
1306 |
Prothrombin |
Prothrombin |
- |
- |
- |
288 [1] 288 💬 |
1307 |
Prothrombin complex concentrate |
Factor IX Complex (Human) |
- |
- |
- |
288 [1] 288 💬 |
1308 |
Proton pump inhibitor (ppi) |
- |
- |
- |
- |
298 [1] 298 💬 |
1309 |
Prototype capsule gdc-0134 |
- |
- |
- |
- |
002 [1] 2 💬 |
1310 |
Provigil |
- |
- |
- |
- |
013 [1] 13 💬 |
1311 |
Provigil (modafinil) |
Modafinil |
[1] D01832 D01832 💬 |
- |
- |
013 [1] 13 💬 |
1312 |
Prozac |
- |
- |
- |
- |
017 [1] 17 💬 |
1313 |
Prp |
- |
- |
- |
- |
090 [1] 90 💬 |
1314 |
Prp injection |
- |
- |
- |
- |
053 [1] 53 💬 |
1315 |
Prtx-100 |
- |
- |
- |
- |
046 [1] 46 💬 |
1316 |
Prtx-100 (staphylococcal protein a) |
Bevifimod |
- |
- |
- |
063 [1] 63 💬 |
1317 |
Prtx-100 at 1.5 mcg/kg |
- |
- |
- |
- |
046 [1] 46 💬 |
1318 |
Prtx-100 at 12.0 mcg/kg |
- |
- |
- |
- |
046 [1] 46 💬 |
1319 |
Prtx-100 at 240 mcg |
- |
- |
- |
- |
046 [1] 46 💬 |
1320 |
Prtx-100 at 3.0 mcg/kg |
- |
- |
- |
- |
046 [1] 46 💬 |
1321 |
Prtx-100 at 420 mcg |
- |
- |
- |
- |
046 [1] 46 💬 |
1322 |
Prtx-100 at 6.0 mcg/kg |
- |
- |
- |
- |
046 [1] 46 💬 |
1323 |
Pru-pla-pla-pru |
- |
- |
- |
- |
099 [1] 99 💬 |
1324 |
Pru-pla-pru-pla |
- |
- |
- |
- |
099 [1] 99 💬 |
1325 |
Prucalopride |
Prucalopride |
[1] D09205 D09205 💬 |
HTR4 [1] HTR4 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway |
013 [3] 13, 51, 96 💬 |
1326 |
Prucalopride succinate |
Prucalopride |
[1] D09205 D09205 💬 |
HTR4 [1] HTR4 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway |
051 [1] 51 💬 |
1327 |
Prv-300 |
- |
- |
- |
- |
097 [1] 97 💬 |
1328 |
Prv-6527 |
- |
- |
- |
- |
096 [1] 96 💬 |
1329 |
Prv-6527 (jnj-40346527) |
JNJ-40346527 |
- |
- |
- |
096 [1] 96 💬 |
1330 |
Prv-6527(jnj-40346527) |
JNJ-40346527 |
- |
- |
- |
096 [1] 96 💬 |
1331 |
Prx-102 |
- |
- |
- |
- |
019 [1] 19 💬 |
1332 |
Prx-102 (pegunigalsidase alfa) |
Pegunigalsidase alfa |
[1] D11685 D11685 💬 |
- |
- |
019 [1] 19 💬 |
1333 |
Prx-112 |
- |
- |
- |
- |
019 [1] 19 💬 |
1334 |
Prx002 |
- |
- |
- |
- |
006 [1] 6 💬 |
1335 |
Prx002, elt2, anti-alpha-synuclein monoclonal antibody |
- |
- |
- |
- |
006 [1] 6 💬 |
1336 |
Prx102 |
- |
- |
- |
- |
019 [1] 19 💬 |
1337 |
Psrs11.efs.il2rg.pre* retroviral vector |
- |
- |
- |
- |
065 [1] 65 💬 |
1338 |
Psrs11.efs.il2rg.pre* retroviral vector transduce |
- |
- |
- |
- |
065 [1] 65 💬 |
1339 |
Psrs11.efs.il2rg.pre* retroviral vector transduced cells |
- |
- |
- |
- |
065 [1] 65 💬 |
1340 |
Pyridoxine plus prednisolone |
Prednisolone |
[10] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02179 D02179, D03301 D03301, D08454 D08454 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
145 [1] 145 💬 |
1341 |
R(+) pramipexole dihydrochloride monohydrate |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 [1] 2 💬 |
1342 |
R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride |
Benzofuran |
- |
- |
- |
006 [1] 6 💬 |
1343 |
R-salbutamol |
Levosalbutamol |
[2] D02147 D02147, D08124 D08124 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
049 [1] 49 💬 |
1344 |
R-salbutamol sulphate |
Levosalbutamol |
[2] D02147 D02147, D08124 D08124 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
049 [1] 49 💬 |
1345 |
Radiation: preparative radiation therapy |
- |
- |
- |
- |
240 [1] 240 💬 |
1346 |
Ranolazine 1000 mg pr tablets |
Ranolazine |
[2] D05700 D05700, D05701 D05701 💬 |
- |
- |
058 [1] 58 💬 |
1347 |
Ranolazine 500 mg pr tablets |
Ranolazine |
[2] D05700 D05700, D05701 D05701 💬 |
- |
- |
058 [1] 58 💬 |
1348 |
Ranolazine 750 mg pr tablets |
Ranolazine |
[2] D05700 D05700, D05701 D05701 💬 |
- |
- |
058 [1] 58 💬 |
1349 |
Ranolazine pr (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die |
Ranolazine |
[2] D05700 D05700, D05701 D05701 💬 |
- |
- |
058 [1] 58 💬 |
1350 |
Rayos (delayed-release prednisone) |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
1351 |
Rebif 44 microgramos solución inyectable en jeringa precargada |
- |
- |
- |
- |
013 [1] 13 💬 |
1352 |
Rebif 44 micrograms solution for injection in pre-filled syringe |
- |
- |
- |
- |
013 [1] 13 💬 |
1353 |
Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack |
- |
- |
- |
- |
013 [1] 13 💬 |
1354 |
Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack. |
- |
- |
- |
- |
013 [1] 13 💬 |
1355 |
Rebif new formulation + ibuprofen prn |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
1356 |
Rebif new formulation + prophylactic ibuprofen |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
1357 |
Recifercept (proposed inn) |
- |
- |
- |
- |
276 [1] 276 💬 |
1358 |
Recombinanat dna-derived human growth hormone produced in e.coli |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
1359 |
Recombinant coagulation fviii fc – von willebrand factor – xten fusion protein |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
1360 |
Recombinant coagulation fviii fc – vonwillebrand factor – xten fusion protein |
- |
- |
- |
- |
288 [1] 288 💬 |
1361 |
Recombinant dna-derived human growth hormone produced in e.coli |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
1362 |
Recombinant factor fc fusion protein |
- |
- |
- |
- |
046 [2] 46, 49 💬 |
1363 |
Recombinant human coagulation factor viii fc - von willebrand factor - xten fusion protein |
Antihemophilic factor human |
- |
- |
- |
288 [1] 288 💬 |
1364 |
Recombinant human erythropoietin |
Erythropoietin |
[1] D03231 D03231 💬 |
EPOR [1] EPOR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
013 [1] 13 💬 |
1365 |
Recombinant human erythropoietin(rhepo) |
Erythropoietin |
[1] D03231 D03231 💬 |
EPOR [1] EPOR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [1] 2 💬 |
1366 |
Recombinant human glucocerebrosidase (prgcd) |
Taliglucerase alfa |
[1] D09675 D09675 💬 |
GBA [1] GBA 💬 |
Lysosome [4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 [1] 19 💬 |
1367 |
Recombinant tnf-a receptor: igg fc fusion protein |
- |
- |
- |
- |
046 [2] 46, 271 💬 |
1368 |
Recombinant truncated spint2 protease inhibitor |
- |
- |
- |
- |
299 [1] 299 💬 |
1369 |
Rectal tacrolimus |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
097 [1] 97 💬 |
1370 |
Reduced intensity preparative regimen |
- |
- |
- |
- |
062 [3] 62, 65, 284 💬 |
1371 |
Rege pro dressing |
- |
- |
- |
- |
036 [1] 36 💬 |
1372 |
Remestemcel-l |
Remestemcel-L |
[1] D09719 D09719 💬 |
- |
- |
096 [2] 96, 97 💬 |
1373 |
Reminder product |
- |
- |
- |
- |
019 [1] 19 💬 |
1374 |
Repaglinide |
Repaglinide |
[1] D00594 D00594 💬 |
ABCC8 [2] ABCC8, KCNJ11 💬 |
ABC transporters [4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
006 [3] 6 , 21, 299 💬 |
1375 |
Repaglinide and insulin |
Repaglinide |
[1] D00594 D00594 💬 |
ABCC8 [2] ABCC8, KCNJ11 💬 |
ABC transporters [4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
299 [1] 299 💬 |
1376 |
Repatha 140 mg solution for injection in pre-filled pen |
- |
- |
- |
- |
079 [1] 79 💬 |
1377 |
Requip pr |
- |
- |
- |
- |
006 [1] 6 💬 |
1378 |
Requip prolonged release |
- |
- |
- |
- |
006 [1] 6 💬 |
1379 |
Requip xl prolonged-release |
- |
- |
- |
- |
006 [1] 6 💬 |
1380 |
Revolade, promacta |
- |
- |
- |
- |
063 [1] 63 💬 |
1381 |
Rhumab beta7, anti beta 7, pro145223 |
- |
- |
- |
- |
097 [1] 97 💬 |
1382 |
Rhumab beta7, anti beta7, pro145223 |
- |
- |
- |
- |
097 [1] 97 💬 |
1383 |
Rifaximin+omeprazole+miralax |
Omeprazole |
[5] D00455 D00455, D01207 D01207, D02554 D02554, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
096 [1] 96 💬 |
1384 |
Riociguat oral product |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
1385 |
Rivastigmine |
Rivastigmine |
[2] D02558 D02558, D03822 D03822 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
005 [3] 5 , 6 , 13 💬 |
1386 |
Rivastigmine capsule |
Rivastigmine |
[2] D02558 D02558, D03822 D03822 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
1387 |
Rivastigmine cf |
Rivastigmine |
[2] D02558 D02558, D03822 D03822 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
1388 |
Rivastigmine luye transdermal patch- 9.5mg/24h |
Rivastigmine |
[2] D02558 D02558, D03822 D03822 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
1389 |
Rivastigmine patch 9.5 cm2 |
Rivastigmine |
[2] D02558 D02558, D03822 D03822 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
1390 |
Rivastigmine transdermal patch |
Rivastigmine |
[2] D02558 D02558, D03822 D03822 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [2] 6 , 13 💬 |
1391 |
Rivastigmine transdermal system |
Rivastigmine |
[2] D02558 D02558, D03822 D03822 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
1392 |
Rivastigmine transdermal system 13.3 mg/24 h |
Rivastigmine |
[2] D02558 D02558, D03822 D03822 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
1393 |
Roactemra 162 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
041 [1] 41 💬 |
1394 |
Roactemra 162 mg solution injectable en seringue préremplie |
- |
- |
- |
- |
046 [1] 46 💬 |
1395 |
Roactemra®ev product code: prd82321 |
- |
- |
- |
- |
046 [1] 46 💬 |
1396 |
Ropinirole hydrochloride prolonged release |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1397 |
Ropinirole oral product |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1398 |
Ropinirole pr |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1399 |
Ropinirole pr, 2mg |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1400 |
Ropinirole pr/xr |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1401 |
Ropinirole pr/xr tablets |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1402 |
Ropinirole prolonged release |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1403 |
Ropinirole prolonged release/extended release(pr/xr) |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1404 |
Rotigotine (reference product pr 2.1.1) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1405 |
Rotigotine (test product pr 2.3.1) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1406 |
Sait101 (proposed rituximab biosimilar) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
1407 |
Salbutamol |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
003 [9] 3 , 11, 49, 85, 86, 111, 228, 256, 299 💬 |
1408 |
Salbutamol 4mg tablet |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 [1] 11 💬 |
1409 |
Salbutamol sulfate |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
111 [1] 111 💬 |
1410 |
Salbutamol sulfate ph. eur. |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 [1] 11 💬 |
1411 |
Salbutamol wzf 4 mg |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 [1] 11 💬 |
1412 |
Salofalk 3g gastro-resistant prolonged-release granules |
- |
- |
- |
- |
097 [1] 97 💬 |
1413 |
Sandostatina - lar 20 mg/2.5 ml polvere e solvente per sospensione iniettabile flacone polvere + siringa preriempita 2.5 ml + 2 aghi |
- |
- |
- |
- |
067 [1] 67 💬 |
1414 |
Sb12 (proposed eculizumab biosimilar) |
Eculizumab |
[1] D03940 D03940 💬 |
C5 [1] C5 💬 |
Complement and coagulation cascades [9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 [1] 62 💬 |
1415 |
Sb2 (proposed biosimilar to infliximab) |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
1416 |
Sb4 (proposed biosimilar to etanercept) |
Etanercept |
[1] D00742 D00742 💬 |
LTA [2] LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
1417 |
Sb5 (proposed biosimilar to adalimumab) |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
1418 |
Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group) |
Amitriptyline |
[7] D00326 D00326, D00809 D00809, D00823 D00823, D01355 D01355, D02691 D02691, D07448 D07448, D08623 D08623 💬 |
GHR [4] GHR, OPRM1, SLC6A2, SLC6A4 💬 |
Cytokine-cytokine receptor interaction [9] Cytokine-cytokine receptor interaction, Estrogen signaling pathway, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Serotonergic synapse, Synaptic vesicle cycle |
078 [1] 78 💬 |
1419 |
Scopolamine, atropine, edaravone and dexmedetomidine |
Atropine |
[9] D00113 D00113, D00138 D00138, D00514 D00514, D01077 D01077, D01205 D01205, D01552 D01552, D02069 D02069, D03011 D03011, D03814 D03814 💬 |
ADRA2A [8] ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 [1] 2 💬 |
1420 |
Secukinumab 150 mg provided in 1.0 ml pre-filled syringes (pfss) for sc injection. |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
271 [1] 271 💬 |
1421 |
Simponi 50 mg solución inyectable en pluma precargada |
- |
- |
- |
- |
046 [1] 46 💬 |
1422 |
Sirolimus oral liquid product 1mg/ml |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
278 [1] 278 💬 |
1423 |
Sirolimus oral product |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
089 [2] 89, 158 💬 |
1424 |
Sitagliptin |
Sitagliptin |
[1] D08516 D08516 💬 |
DPP4 [1] DPP4 💬 |
Protein digestion and absorption [1] Protein digestion and absorption |
006 [4] 6 , 75, 233, 299 💬 |
1425 |
Sitagliptin and metformin |
Metformin |
[3] D00944 D00944, D04966 D04966, D08516 D08516 💬 |
DPP4 [3] DPP4, PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [20] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Protein digestion and absorption, Thermogenesis, Tight junction, mTOR signaling pathway |
233 [1] 233 💬 |
1426 |
Solu-cortef (hydrocortisone) |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
083 [1] 83 💬 |
1427 |
Soluble prednisolone tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
145 [1] 145 💬 |
1428 |
Sotatercept with prednisone boost |
Prednisone |
[2] D00473 D00473, D09670 D09670 💬 |
ACVR2A [2] ACVR2A, NR3C1 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Neuroactive ligand-receptor interaction, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway |
284 [1] 284 💬 |
1429 |
Soy protein |
- |
- |
- |
- |
006 [2] 6 , 96 💬 |
1430 |
Soy protein isolate |
- |
- |
- |
- |
227 [1] 227 💬 |
1431 |
Staphylococcal protein a |
Bevifimod |
- |
- |
- |
063 [1] 63 💬 |
1432 |
Stelara 90 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
096 [1] 96 💬 |
1433 |
Stem/progenitor cells transplantation |
- |
- |
- |
- |
090 [2] 90, 301 💬 |
1434 |
Steroid and proton pump inhibitor therapy |
- |
- |
- |
- |
098 [1] 98 💬 |
1435 |
Strontium ranelate |
Strontium ranelate |
[1] D08468 D08468 💬 |
- |
- |
078 [1] 78 💬 |
1436 |
Study of the gene expression profile |
- |
- |
- |
- |
051 [1] 51 💬 |
1437 |
Subcutaneous and intravenous prostacyclin |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
1438 |
Subcutaneous hydrocortisone |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
1439 |
Subcutaneous hydrocortisone 10mg |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
1440 |
Subretinal injection of umbilical cord blood platelet-rich plasma (cb-prp) |
- |
- |
- |
- |
090 [1] 90 💬 |
1441 |
Sulphasalazine + hydroxychloroquine or prednisolone |
Hydroxychloroquine |
[9] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301, D08050 D08050 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
1442 |
Sustanon (testosterone) |
Testosterone |
[6] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
113 [1] 113 💬 |
1443 |
Symptomatic treatment, steroids, immunosuppressive agents( azathioprine, tacrolimus, mycophenolate mofetil) |
Azathioprine |
[8] D00107 D00107, D00238 D00238, D00752 D00752, D03033 D03033, D05094 D05094, D05095 D05095, D05096 D05096, D08556 D08556 💬 |
IMPDH1 [7] IMPDH1, IMPDH2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [35] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 [1] 11 💬 |
1444 |
Synthetic preimplantation factor |
Preimplantation factor |
- |
- |
- |
095 [1] 95 💬 |
1445 |
T-cell depleted & cd34+select/w/stemcell enriched product |
- |
- |
- |
- |
065 [1] 65 💬 |
1446 |
Tabalumab prefilled syringe |
Tabalumab |
[1] D10083 D10083 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
046 [2] 46, 49 💬 |
1447 |
Tacrolimus |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 [32] 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
1448 |
Tacrolimus (advagraf) |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
227 [1] 227 💬 |
1449 |
Tacrolimus (prograf®) |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
1450 |
Tacrolimus (tacro) |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
065 [1] 65 💬 |
1451 |
Tacrolimus and mmf |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
299 [1] 299 💬 |
1452 |
Tacrolimus capsule |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 [1] 11 💬 |
1453 |
Tacrolimus capsule (low-dose) |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
227 [1] 227 💬 |
1454 |
Tacrolimus capsules |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
222 [2] 222, 299 💬 |
1455 |
Tacrolimus combined with prednisone |
Prednisone |
[3] D00107 D00107, D00473 D00473, D08556 D08556 💬 |
NR3C1 [6] NR3C1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
222 [1] 222 💬 |
1456 |
Tacrolimus prolonged-release hard capsules |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
299 [1] 299 💬 |
1457 |
Tacrolimus tablets |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
1458 |
Tacrolimus with methotrexate |
Methotrexate |
[4] D00107 D00107, D00142 D00142, D02115 D02115, D08556 D08556 💬 |
DHFR [7] DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [37] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
1459 |
Taltz (80 mg solution for injection in pre-filled syringe) |
- |
- |
- |
- |
271 [1] 271 💬 |
1460 |
Targinact 10 mg/5 mg prolonged-release tablets |
- |
- |
- |
- |
006 [2] 6 , 226 💬 |
1461 |
Targinact 20 mg/10 mg prolonged-release tablets |
- |
- |
- |
- |
006 [1] 6 💬 |
1462 |
Targinact 20mg/10 mg prolonged-release tablets |
- |
- |
- |
- |
226 [1] 226 💬 |
1463 |
Targinact 5 mg/2.5 mg prolonged-release tablets |
- |
- |
- |
- |
006 [1] 6 💬 |
1464 |
Targinact 5mg/2.5 mg prolonged-release tablets |
- |
- |
- |
- |
226 [1] 226 💬 |
1465 |
Tasocitinib (proposed inn) |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [1] 46 💬 |
1466 |
Tch346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt) |
Hydrogen |
- |
- |
- |
006 [1] 6 💬 |
1467 |
Testosterone |
Testosterone |
[6] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
001 [8] 1 , 2 , 3 , 13, 60, 78, 113, 265 💬 |
1468 |
Testosterone decanoate |
Testosterone |
[7] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087, D08573 D08573 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
113 [1] 113 💬 |
1469 |
Testosterone enanthate |
Testosterone |
[6] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
113 [1] 113 💬 |
1470 |
Testosterone isocaproate |
Testosterone |
[6] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
113 [1] 113 💬 |
1471 |
Testosterone phenylpropionate |
Testosterone |
[7] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087, D08574 D08574 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
113 [1] 113 💬 |
1472 |
Testosterone plus somatropin |
Somatotropin |
[7] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D02691 D02691, D06085 D06085, D06087 D06087 💬 |
AR [2] AR, GHR 💬 |
Cytokine-cytokine receptor interaction [8] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer |
078 [1] 78 💬 |
1473 |
Testosterone propionate |
Testosterone |
[6] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
113 [1] 113 💬 |
1474 |
Testosterone undecanoate |
Testosterone |
[6] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
013 [2] 13, 60 💬 |
1475 |
Thalidomide, cyclophosphamide and prednisone |
Cyclophosphamide |
[4] D00287 D00287, D00473 D00473, D00754 D00754, D07760 D07760 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
331 [1] 331 💬 |
1476 |
The generic name is warfarin and many producers will be involved |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
049 [1] 49 💬 |
1477 |
The gut mycobiota and microbiota profile |
- |
- |
- |
- |
299 [1] 299 💬 |
1478 |
The investigational medicinal product (imp) may be labelled as either pf-04236921 106 mg/vial, clonal sc lyophilized form” or pf-04236921 powder for injection, 106 mg/vial”. supplies labelled with either nomenclature are equivalent. |
- |
- |
- |
- |
096 [1] 96 💬 |
1479 |
The investigational medicinal product (imp) will be labeled as pf-04236921 106 mg/vial, clonal sc lyophilized form, which is equivalent to pf-04236921 powder for injection, 106 mg/vial as described in the enclosed cta |
- |
- |
- |
- |
096 [1] 96 💬 |
1480 |
The investigational medicinal product (imp) will be labeled as pf-04236921 106 mg/vial, clonal sc lyophilized form, which is equivalent to pf-04236921 powder for injection, 106 mg/vial as described in the enclosed cta. |
- |
- |
- |
- |
096 [1] 96 💬 |
1481 |
The lung mycobiota and microbiota profile |
- |
- |
- |
- |
299 [1] 299 💬 |
1482 |
The pop02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: |
- |
- |
- |
- |
086 [1] 86 💬 |
1483 |
The pops study is collecting pk data on children prescribed the following drugs of interest per standard of care: |
- |
- |
- |
- |
086 [1] 86 💬 |
1484 |
Tildrakizumab prefilled syringe |
Tildrakizumab |
[1] D10400 D10400 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
162 [1] 162 💬 |
1485 |
Tobi inhalant product |
- |
- |
- |
- |
299 [1] 299 💬 |
1486 |
Tocilizumab prefilled syringe |
Tocilizumab |
[1] D02596 D02596 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 [1] 46 💬 |
1487 |
Tocilizumab sc 162 mg/0.9 ml pre-filled syringe with safety device (pfs) |
Tocilizumab |
[1] D02596 D02596 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 [1] 46 💬 |
1488 |
Tocilizumab sc 162 mg/0.9 ml prefilled syringe with safety device (pfs) |
Tocilizumab |
[1] D02596 D02596 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
051 [1] 51 💬 |
1489 |
Tofacitinib (xeljanz®) 11mg prolonged release tablet |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [1] 46 💬 |
1490 |
Tofacitinib citrate (proposed commercial formulation - debossed) |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [2] 46, 97 💬 |
1491 |
Tofacitinib citrate (proposed commercial formulation debossed) |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [1] 46 💬 |
1492 |
Tofacitinib citrate (proposed commercial formulation – debossed) |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [2] 46, 97 💬 |
1493 |
Tofacitinib citrate (proposed commercial formulation- debossed) |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [1] 46 💬 |
1494 |
Tofacitinib citrate (proposed commercialformulation - debossed) |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
097 [1] 97 💬 |
1495 |
Topical preparation h arm |
- |
- |
- |
- |
013 [1] 13 💬 |
1496 |
Trade name depends on the source of the product |
- |
- |
- |
- |
076 [1] 76 💬 |
1497 |
Trade name depends on the source of the product’ |
- |
- |
- |
- |
076 [1] 76 💬 |
1498 |
Transcon peg40 hgh, transiently pegylated hgh prodrug |
- |
- |
- |
- |
078 [1] 78 💬 |
1499 |
Transdermal testosterone gel |
Testosterone |
[6] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
078 [1] 78 💬 |
1500 |
Transiently pegylated hgh prodrug |
- |
- |
- |
- |
078 [1] 78 💬 |
1501 |
Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan |
Alemtuzumab |
[5] D00369 D00369, D00583 D00583, D01907 D01907, D02802 D02802, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
065 [2] 65, 164 💬 |
1502 |
Treat with lansoprazole 30 mg bid for 2 weeks, endoscopic examination with esophageal biopsy for patients with persistent symptoms |
Lansoprazole |
[1] D00355 D00355 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
098 [1] 98 💬 |
1503 |
Treatment systemic therapy (prednisone) |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
162 [1] 162 💬 |
1504 |
Treatment with systemic therapy (prednisone) |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
162 [1] 162 💬 |
1505 |
Treprostinil injectable product |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
1506 |
Trexan+salazopyrin+oxiklorin+prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
1507 |
Trexan+salazopyrin+oxiklorin+prednisolone + infliximab |
Infliximab |
[9] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02598 D02598, D03301 D03301 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
1508 |
Triamcinolone |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [8] 35, 46, 56, 70, 90, 96, 226, 298 💬 |
1509 |
Triamcinolone 40 milligrams (kenacort, bristol myers squip) |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
1510 |
Triamcinolone acetonide |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [3] 35, 46, 56 💬 |
1511 |
Triamcinolone acetonide and normal saline solution |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
070 [1] 70 💬 |
1512 |
Triamcinolone hexacetonid (lederspan) |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
1513 |
Triamcinolone hexacetonide |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
1514 |
Triamcinolone hexacetonide (lederspan) |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
1515 |
Trimethoprim |
Trimethoprim |
[2] D00145 D00145, D06236 D06236 💬 |
- |
- |
036 [6] 36, 44, 49, 60, 85, 299 💬 |
1516 |
Trimethoprim and sulfamethoxazole |
Sulfamethoxazole |
[3] D00145 D00145, D00447 D00447, D06236 D06236 💬 |
- |
- |
299 [1] 299 💬 |
1517 |
Trimethoprim sulfamethoxazole |
Sulfamethoxazole |
[3] D00145 D00145, D00447 D00447, D06236 D06236 💬 |
- |
- |
044 [1] 44 💬 |
1518 |
Trimethoprim sulfamethoxazole (tmp/smx) |
Sulfamethoxazole |
[3] D00145 D00145, D00447 D00447, D06236 D06236 💬 |
- |
- |
299 [1] 299 💬 |
1519 |
Trimethoprim sulfate |
Sulfate ion |
[2] D00145 D00145, D06236 D06236 💬 |
- |
- |
060 [1] 60 💬 |
1520 |
Trimethoprim-sulfamethoxazole |
Sulfamethoxazole |
[3] D00145 D00145, D00447 D00447, D06236 D06236 💬 |
- |
- |
049 [2] 49, 299 💬 |
1521 |
Trimethoprim/sulfamethoxazole |
Sulfamethoxazole |
[3] D00145 D00145, D00447 D00447, D06236 D06236 💬 |
- |
- |
299 [1] 299 💬 |
1522 |
Trimethoprim/sulfamethoxazole (tmp/smx) |
Sulfamethoxazole |
[3] D00145 D00145, D00447 D00447, D06236 D06236 💬 |
- |
- |
299 [1] 299 💬 |
1523 |
Ursodeoxycholic acid+low dose glucocorticoid(prednisone) |
Prednisone |
[2] D00473 D00473, D00734 D00734 💬 |
NR1H4 [2] NR1H4, NR3C1 💬 |
Bile secretion [2] Bile secretion, Neuroactive ligand-receptor interaction |
093 [1] 93 💬 |
1524 |
Us tap bupivacaine/epinephrine |
Bupivacaine |
[5] D00095 D00095, D00996 D00996, D01450 D01450, D02149 D02149, D07552 D07552 💬 |
ADRA1A [14] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [15] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [1] 96 💬 |
1525 |
Ustekinumab liquid in prefilled syringe |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
084 [1] 84 💬 |
1526 |
Valproate, levocarnitine |
Levocarnitine |
[4] D00399 D00399, D02030 D02030, D02176 D02176, D04713 D04713 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 [1] 3 💬 |
1527 |
Valproic acid and levocarnitine |
Levocarnitine |
[4] D00399 D00399, D02030 D02030, D02176 D02176, D04713 D04713 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 [1] 3 💬 |
1528 |
Vancomycin pre-treat |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
097 [1] 97 💬 |
1529 |
Vancomycin pre-treatment |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
097 [1] 97 💬 |
1530 |
Vivomixx probiotics |
- |
- |
- |
- |
051 [1] 51 💬 |
1531 |
Vwf-containing products |
- |
- |
- |
- |
288 [1] 288 💬 |
1532 |
Vwf/fviii products |
- |
- |
- |
- |
288 [1] 288 💬 |
1533 |
Whey protein |
- |
- |
- |
- |
006 [2] 6 , 96 💬 |
1534 |
Whey protein&prebiotic supplement |
- |
- |
- |
- |
046 [1] 46 💬 |
1535 |
Z102 (prednisolone and dipyridamole). |
Dipyridamole |
[9] D00302 D00302, D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [3] NR3C1, PDE4A, PDE5A 💬 |
Metabolic pathways [7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
1536 |
Zavesca® prescription |
- |
- |
- |
- |
256 [1] 256 💬 |
1537 |
Zoledronic acid kern pharma 4 mg/100 ml solution for infusion, generic medicinal product |
Zoledronic acid |
[4] D01968 D01968, D06378 D06378, D06379 D06379, D08689 D08689 💬 |
FDPS [1] FDPS 💬 |
Human T-cell leukemia virus 1 infection [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
274 [1] 274 💬 |
1538 |
Zoledronic acid kern pharma 4 mg/100 ml solution for infusion, generic medicinal product. |
Zoledronic acid |
[4] D01968 D01968, D06378 D06378, D06379 D06379, D08689 D08689 💬 |
FDPS [1] FDPS 💬 |
Human T-cell leukemia virus 1 infection [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
274 [1] 274 💬 |
1539 |
Zoledronic acid kern pharma 4 mg/100 ml solution for infusion,generic medicinal product |
Zoledronic acid |
[4] D01968 D01968, D06378 D06378, D06379 D06379, D08689 D08689 💬 |
FDPS [1] FDPS 💬 |
Human T-cell leukemia virus 1 infection [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
274 [1] 274 💬 |
1540 |
Zoledronic acid, pravastatin |
Pravastatin |
[6] D00893 D00893, D01968 D01968, D06378 D06378, D06379 D06379, D08410 D08410, D08689 D08689 💬 |
FDPS [2] FDPS, HMGCR 💬 |
AMPK signaling pathway [6] AMPK signaling pathway, Bile secretion, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
333 [1] 333 💬 |